Distinctive	O
expression	O
pattern	O
of	O
the	O
BCL-6	B-protein
protein	I-protein
in	O
nodular	O
lymphocyte	O
predominance	O
Hodgkin	O
's	O
disease	O
.	O

The	O
BCL-6	B-RNA
gene	I-RNA
encoding	O
a	O
nuclear-located	B-protein
Kruppel-type	I-protein
zinc	I-protein
finger	I-protein
protein	I-protein
is	O
rearranged	O
in	O
about	O
30	O
%	O
diffuse	O
large	O
B-cell	B-cell_type
lymphomas	I-cell_type
and	O
is	O
expressed	O
predominantly	O
in	O
normal	O
germinal	B-cell_type
center	I-cell_type
B	I-cell_type
cells	I-cell_type
and	O
related	O
lymphomas	O
.	O

These	O
findings	O
suggest	O
that	O
BCL-6	B-protein
may	O
play	O
a	O
role	O
in	O
regulating	O
differentiation	O
of	O
normal	O
germinal	B-cell_type
center	I-cell_type
B	I-cell_type
cells	I-cell_type
and	O
that	O
its	O
deregulated	O
expression	O
caused	O
by	O
rearrangements	O
may	O
contribute	O
to	O
lymphomagenesis	O
.	O

This	O
prompted	O
us	O
to	O
investigate	O
the	O
expression	O
of	O
the	O
BCL-6	B-protein
protein	I-protein
in	O
Hodgkin	O
's	O
disease	O
(	O
HD	O
)	O
,	O
focusing	O
on	O
the	O
nodular	O
lymphocyte	O
predominance	O
subtype	O
(	O
NLPHD	O
)	O
,	O
which	O
differs	O
from	O
classical	O
HD	O
by	O
virtue	O
of	O
the	O
B-cell	O
nature	O
of	O
the	O
malignant	B-cell_type
cell	I-cell_type
population	I-cell_type
(	O
so-called	O
L	B-cell_type
&	I-cell_type
H	I-cell_type
cells	I-cell_type
)	O
and	O
its	O
relationship	O
with	O
germinal	O
centers	O
.	O

Forty-one	O
HD	O
samples	O
(	O
19	O
NLPHD	O
,	O
12	O
nodular	O
sclerosis	O
,	O
and	O
10	O
mixed	O
cellularity	O
)	O
were	O
immunostained	O
with	O
the	O
monoclonal	B-protein
antibodies	I-protein
PG-B6	B-protein
and	O
PG-B6p	B-protein
that	O
react	O
with	O
a	O
fixative-sensitive	O
and	O
a	O
formalin-resistant	B-protein
epitope	I-protein
on	O
the	O
aminoterminal	B-protein
region	I-protein
of	O
the	O
BCL-6	B-protein
gene	I-protein
product	I-protein
,	O
respectively	O
.	O

Strong	O
nuclear	O
positivity	O
for	O
the	O
BCL-6	B-protein
protein	I-protein
was	O
detected	O
in	O
tumor	B-cell_type
(	I-cell_type
L	I-cell_type
&	I-cell_type
H	I-cell_type
)	I-cell_type
cells	I-cell_type
in	O
all	O
cases	O
of	O
NLPHD	O
.	O

In	O
contrast	O
,	O
BCL-6	B-protein
was	O
expressed	O
only	O
in	O
a	O
small	O
percentage	O
of	O
Hodgkin	B-cell_line
and	I-cell_line
Reed-Sternberg	I-cell_line
cells	I-cell_line
in	O
about	O
30	O
%	O
of	O
classical	O
HD	O
cases	O
.	O

Notably	O
,	O
the	O
nuclei	O
of	O
reactive	B-cell_type
CD3+/CD4+	I-cell_type
T	I-cell_type
cells	I-cell_type
nearby	O
to	O
and	O
rosetting	O
around	O
L	B-cell_type
&	I-cell_type
H	I-cell_type
cells	I-cell_type
in	O
NLPHD	O
were	O
also	O
strongly	O
BCL-6	B-protein
+	O
,	O
but	O
lacked	O
CD40	B-protein
ligand	I-protein
(	O
CD40L	B-protein
)	O
expression	O
.	O

This	O
staining	O
pattern	O
clearly	O
differed	O
from	O
that	O
of	O
classical	O
HD	O
,	O
whose	O
cellular	O
background	O
was	O
made	O
up	O
of	O
CD3+/CD4+	B-cell_type
T	I-cell_type
cells	I-cell_type
showing	O
the	O
BCL-6	B-protein
-/	O
CD40L	B-protein
+	O
phenotype	O
.	O

These	O
results	O
further	O
support	O
the	O
concept	O
that	O
NLPHD	O
is	O
an	O
histogenetically	O
distinct	O
,	O
B-cell-derived	O
subtype	O
of	O
HD	O
and	O
suggest	O
a	O
role	O
for	O
BCL-6	B-protein
in	O
its	O
development	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RAPID	NULL
COMMUNICATION	NULL
Distinctive	NULL
Expression	NULL
Pattern	NULL
of	NULL
the	NULL
BCL-6	NULL
Protein	NULL
in	NULL
Nodular	NULL
Lymphocyte	NULL
Predominance	NULL
Hodgkin	NULL
's	NULL
Disease	NULL
By	NULL
Brunangelo	NULL
Falini	NULL
,	NULL
Barbara	NULL
Bigerna	NULL
,	NULL
Laura	NULL
Pasqualucci	NULL
,	NULL
Marco	NULL
Fizzotti	NULL
,	NULL
Massimo	NULL
F.	NULL
Martelli	NULL
,	NULL
Stefano	NULL
Pileri	NULL
,	NULL
Antonio	NULL
Pinto	NULL
,	NULL
Antonino	NULL
Carbone	NULL
,	NULL
Stefania	NULL
Venturi	NULL
,	NULL
Roberta	NULL
Pacini	NULL
,	NULL
Giorgio	NULL
Cattoretti	NULL
,	NULL
Edoardo	NULL
Pescarmona	NULL
,	NULL
Francesco	NULL
Lo	NULL
Coco	NULL
,	NULL
Pier-Giuseppe	NULL
Pelicci	NULL
,	NULL
loannis	NULL
Anagnastopoulos	NULL
,	NULL
Riccardo	NULL
Dalla-Favera	NULL
,	NULL
and	NULL
Leonardo	NULL
Flenghi	NULL
The	NULL
BCL-6	NULL
gene	NULL
encoding	NULL
a	NULL
nuclear-located	NULL
Kruppel-type	NULL
zinc	NULL
finger	NULL
protein	NULL
is	NULL
rearranged	NULL
in	NULL
about	NULL
30	NULL
%	NULL
diffuse	NULL
large	NULL
B-cell	NULL
lymphomas	NULL
and	NULL
is	NULL
expressed	NULL
predominantly	NULL
in	NULL
normal	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
and	NULL
related	NULL
lymphomas	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
BCL-6	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
regulating	NULL
differentiation	NULL
of	NULL
normal	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
and	NULL
that	NULL
its	NULL
deregulated	NULL
expression	NULL
caused	NULL
by	NULL
rearrangements	NULL
may	NULL
contribute	NULL
to	NULL
lymphomagenesis	NULL
.	NULL

This	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
(	NULL
HD	NULL
)	NULL
,	NULL
focusing	NULL
on	NULL
the	NULL
nodular	NULL
lymphocyte	NULL
predominance	NULL
subtype	NULL
(	NULL
NLPHD	NULL
)	NULL
,	NULL
which	NULL
differs	NULL
from	NULL
classical	NULL
HD	NULL
by	NULL
virtue	NULL
of	NULL
the	NULL
B-cell	NULL
nature	NULL
of	NULL
the	NULL
malignant	NULL
cell	NULL
population	NULL
{	NULL
so-called	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
)	NULL
and	NULL
its	NULL
relationship	NULL
with	NULL
germinal	NULL
cen-ters	NULL
.	NULL

Forty-one	NULL
HD	NULL
samples	NULL
(	NULL
19	NULL
NLPHD	NULL
,	NULL
12	NULL
nodular	NULL
sclerosis	NULL
,	NULL
and	NULL
10	NULL
mixed	NULL
cellularity	NULL
)	NULL
were	NULL
immunostained	NULL
with	NULL
the	NULL
monoclonal	NULL
antibodies	NULL
PG-B6	NULL
and	NULL
PG-B6p	NULL
that	NULL
react	NULL
with	NULL
HE	NULL
BCL-6	NULL
GENE	NULL
IS	NULL
frequently	NULL
involved	NULL
in	NULL
translocations	NULL
affecting	NULL
band	NULL
3q27'*	NULL
and	NULL
is	NULL
found	NULL
rearranged	NULL
in	NULL
about	NULL
30	NULL
%	NULL
non-Hodgkin	NULL
lymphomas	NULL
of	NULL
diffuse	NULL
large	NULL
B-cell	NULL
type	NULL
(	NULL
DLCL-B	NULL
)	NULL
and	NULL
in	NULL
a	NULL
small	NULL
fraction	NULL
of	NULL
follicular	NULL
lympho-mas	NULL
.	NULL
``	NULL

The	NULL
BCL-6	NULL
gene	NULL
encodes	NULL
a	NULL
protein	NULL
of	NULL
706	NULL
amino	NULL
acids	NULL
that	NULL
has	NULL
homologies	NULL
with	NULL
members	NULL
of	NULL
the	NULL
Kruppel-like	NULL
sub-family	NULL
of	NULL
zinc	NULL
finger	NULL
proteins	NULL
,	NULL
``	NULL
many	NULL
of	NULL
which	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
developmental	NULL
regulation	NULL
.	NULL
``	NULL

Immunohistologic	NULL
studies	NULL
of	NULL
normal	NULL
lymphoid	NULL
tissues	NULL
with	NULL
specific	NULL
poly-clonal®*	NULL
``	NULL
``	NULL
and	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
MoAbs	NULL
)	NULL
``	NULL
have	NULL
provided	NULL
evidence	NULL
that	NULL
BCL-6	NULL
is	NULL
a	NULL
nuclear-located	NULL
protein	NULL
preferentially	NULL
expressed	NULL
in	NULL
virtually	NULL
all	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
(	NULL
centroblasts	NULL
and	NULL
centrocytes	NULL
)	NULL
of	NULL
the	NULL
secondary	NULL
follicles	NULL
.	NULL

This	NULL
finding	NULL
strongly	NULL
suggests	NULL
that	NULL
BCL-6	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
B-cell	NULL
differentiation	NULL
occurring	NULL
within	NULL
the	NULL
germinal	NULL
centers	NULL
of	NULL
peripheral	NULL
lymphoid	NULL
organs	NULL
.	NULL
``	NULL

Among	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
,	NULL
the	NULL
BCL-6	NULL
protein	NULL
is	NULL
mainly	NULL
expressed	NULL
on	NULL
those	NULL
B-cell	NULL
subtypes	NULL
presumably	NULL
derived	NULL
from	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
(	NULL
follicular	NULL
lymphomas	NULL
and	NULL
DLCL-B	NULL
)	NULL
.	NULL

In	NULL
these	NULL
tumors	NULL
,	NULL
the	NULL
BCL-6	NULL
gene	NULL
is	NULL
expressed	NULL
independently	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
rearrangements	NULL
.	NULL
``	NULL

''	NULL
'	NULL
In	NULL
those	NULL
cases	NULL
carrying	NULL
rearrangements	NULL
,	NULL
BCL-6	NULL
expression	NULL
is	NULL
driven	NULL
by	NULL
heterologous	NULL
promoters	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
may	NULL
be	NULL
deregu-lated	NULL
.	NULL
``	NULL

Given	NULL
the	NULL
restricted	NULL
expression	NULL
of	NULL
BCL-6	NULL
to	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
were	NULL
particularly	NULL
interested	NULL
to	NULL
study	NULL
the	NULL
distribution	NULL
of	NULL
this	NULL
protein	NULL
in	NULL
nodular	NULL
lymphocyte	NULL
predominance	NULL
Hodgkin	NULL
's	NULL
disease	NULL
(	NULL
NLPHD	NULL
)	NULL
,	NULL
which	NULL
differs	NULL
from	NULL
other	NULL
subtypes	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
(	NULL
HD	NULL
)	NULL
by	NULL
virtue	NULL
of	NULL
the	NULL
B-cell	NULL
nature	NULL
of	NULL
the	NULL
tumor	NULL
component	NULL
(	NULL
so-called	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
)	NULL
and	NULL
its	NULL
relationship	NULL
with	NULL
germinal	NULL
centers	NULL
.	NULL
'	NULL

''	NULL
*	NULL
``	NULL
``	NULL
For	NULL
this	NULL
purpose	NULL
,	NULL
tissue	NULL
sections	NULL
from	NULL
different	NULL
subtypes	NULL
of	NULL
HD	NULL
were	NULL
immunostained	NULL
with	NULL
two	NULL
MoAbs	NULL
,	NULL
PG-B6	NULL
``	NULL
and	NULL
PG-B6p	NULL
,	NULL
``	NULL
°	NULL
that	NULL
react	NULL
with	NULL
a	NULL
fixative-sensitive	NULL
and	NULL
fixative-resistant	NULL
epitope	NULL
on	NULL
the	NULL
aminoterminal	NULL
region	NULL
of	NULL
human	NULL
BCL-6	NULL
protein	NULL
,	NULL
respectively	NULL
.	NULL

Blood	NULL
,	NULL
Vol	NULL
87	NULL
,	NULL
No	NULL
2	NULL
(	NULL
January	NULL
15	NULL
)	NULL
,	NULL
1996	NULL
:	NULL
pp	NULL
465-471	NULL
a	NULL
fixative-sensitive	NULL
and	NULL
a	NULL
formalin-resistant	NULL
epitope	NULL
on	NULL
the	NULL
aminoterminal	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
product	NULL
,	NULL
respectively	NULL
.	NULL

Strong	NULL
nuclear	NULL
positivity	NULL
for	NULL
the	NULL
BCL-6	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
tumor	NULL
(	NULL
L	NULL
&	NULL
H	NULL
)	NULL
cells	NULL
in	NULL
all	NULL
cases	NULL
of	NULL
NLPHD	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
BCL-6	NULL
was	NULL
expressed	NULL
only	NULL
in	NULL
a	NULL
small	NULL
percentage	NULL
of	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
in	NULL
about	NULL
30	NULL
%	NULL
of	NULL
classical	NULL
HD	NULL
cases	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
nuclei	NULL
of	NULL
reactive	NULL
CD3*/CD4*	NULL
T	NULL
cells	NULL
nearby	NULL
to	NULL
and	NULL
rosetting	NULL
around	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
in	NULL
NLPHD	NULL
were	NULL
also	NULL
strongly	NULL
BCL-6*	NULL
,	NULL
but	NULL
lacked	NULL
CD40	NULL
ligand	NULL
(	NULL
CD4O0L	NULL
)	NULL
expres-sion	NULL
.	NULL

This	NULL
staining	NULL
pattern	NULL
clearly	NULL
differed	NULL
from	NULL
that	NULL
of	NULL
classical	NULL
HD	NULL
,	NULL
whose	NULL
cellular	NULL
background	NULL
was	NULL
made	NULL
up	NULL
of	NULL
CD3*/	NULL
CD4*	NULL
T	NULL
cells	NULL
showing	NULL
the	NULL
BCL-6~/CD40L*	NULL
phenotype	NULL
.	NULL

These	NULL
results	NULL
further	NULL
support	NULL
the	NULL
concept	NULL
that	NULL
NLPHD	NULL
is	NULL
an	NULL
histo-genetically	NULL
distinct	NULL
,	NULL
B-cell-derived	NULL
subtype	NULL
of	NULL
HD	NULL
and	NULL
suggest	NULL
a	NULL
role	NULL
for	NULL
BCL-6	NULL
in	NULL
its	NULL
development	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

We	NULL
provide	NULL
in	NULL
this	NULL
report	NULL
immunohistological	NULL
evidence	NULL
for	NULL
a	NULL
distinctive	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
in	NULL
NLPHD	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
mixed	NULL
cellularity	NULL
(	NULL
MC	NULL
)	NULL
and	NULL
nodular	NULL
sclerosis	NULL
(	NULL
NS	NULL
)	NULL
HD	NULL
subtypes	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Antibodies	NULL
The	NULL
BCL-6	NULL
protein	NULL
was	NULL
detected	NULL
by	NULL
using	NULL
the	NULL
MoAbs	NULL
PG-B6	NULL
and	NULL
PG-B6p	NULL
that	NULL
have	NULL
been	NULL
recently	NULL
generated	NULL
in	NULL
the	NULL
laboratory	NULL
of	NULL
one	NULL
of	NULL
the	NULL
investigators	NULL
(	NULL
B.F.	NULL
)	NULL
by	NULL
immunizing	NULL
BALB/c	NULL
mice	NULL
with	NULL
a	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-BCL6-fusion	NULL
protein	NULL
.	NULL
'	NULL

''	NULL
*	NULL
Both	NULL
antibodies	NULL
are	NULL
directed	NULL
against	NULL
the	NULL
aminoterminal	NULL
portion	NULL
of	NULL
the	NULL
human	NULL
BCL-6	NULL
gene	NULL
product	NULL
,	NULL
but	NULL
probably	NULL
recognize	NULL
different	NULL
epitopes	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
PG-B6	NULL
and	NULL
PG-B6p	NULL
show	NULL
the	NULL
same	NULL
immunostaining	NULL
pattern	NULL
in	NULL
fresh	NULL
samples	NULL
,	NULL
but	NULL
only	NULL
the	NULL
MoAb	NULL
PG-B6p	NULL
allows	NULL
detection	NULL
of	NULL
BCL6	NULL
in	NULL
microwave-heated	NULL
paraffin	NULL
sections	NULL
.	NULL
``	NULL

HD	NULL
cases	NULL
were	NULL
immunostained	NULL
in	NULL
parallel	NULL
with	NULL
two	NULL
rabbit	NULL
poly-	NULL
From	NULL
the	NULL
Institutes	NULL
of	NULL
Hematology	NULL
and	NULL
Internal	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Perugia	NULL
,	NULL
Perugia	NULL
,	NULL
Italy	NULL
;	NULL
the	NULL
Institute	NULL
of	NULL
Hematology	NULL
,	NULL
University	NULL
of	NULL
Bologna	NULL
,	NULL
Bologna	NULL
,	NULL
Italy	NULL
;	NULL
the	NULL
``	NULL
Leukemia	NULL
Unit	NULL
'	NULL
``	NULL
and	NULL
Division	NULL
of	NULL
Pathology	NULL
,	NULL
Centro	NULL
Riferimento	NULL
Oncologico	NULL
,	NULL
Aviano	NULL
,	NULL
Italy	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
NY	NULL
;	NULL
the	NULL
Institutes	NULL
of	NULL
Pathology	NULL
and	NULL
Hematology	NULL
,	NULL
University	NULL
``	NULL
La	NULL
Sapienza	NULL
``	NULL
,	NULL
Rome	NULL
,	NULL
Italy	NULL
;	NULL
and	NULL
the	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
Free	NULL
University	NULL
of	NULL
Berlin	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
.	NULL

Submitted	NULL
August	NULL
24	NULL
,	NULL
1995	NULL
;	NULL
accepted	NULL
October	NULL
25	NULL
,	NULL
1995	NULL
.	NULL

Supported	NULL
by	NULL
the	NULL
Associazione	NULL
Italiana	NULL
Ricerca	NULL
Cancro	NULL
(	NULL
AIRC	NULL
)	NULL
,	NULL
the	NULL
CNR	NULL
(	NULL
Sottoprogetti	NULL
ACRO	NULL
)	NULL
,	NULL
and	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
No	NULL
.	NULL

CA-44029	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Brunangelo	NULL
Falini	NULL
,	NULL
MD	NULL
,	NULL
Istituto	NULL
di	NULL
Ematologia	NULL
,	NULL
Policlinico	NULL
,	NULL
Monteluce	NULL
,	NULL
06100	NULL
Perugia	NULL
,	NULL
Italy	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/96/8702-0050	NULL
$	NULL
3.00/0	NULL
465	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

466	NULL
clonal	NULL
anti~BCL-6	NULL
antibodies	NULL
.	NULL

The	NULL
polyclonal	NULL
antibody	NULL
N-70-6	NULL
(	NULL
anti-N-terminus	NULL
)	NULL
was	NULL
raised	NULL
in	NULL
the	NULL
laboratory	NULL
of	NULL
one	NULL
of	NULL
the	NULL
investigators	NULL
(	NULL
R.D.F	NULL
.	NULL
)	NULL

and	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

BCL-6	NULL
(	NULL
N-3	NULL
)	NULL
is	NULL
an	NULL
affinity-purified	NULL
polyclonal	NULL
antibody	NULL
raised	NULL
against	NULL
a	NULL
GST	NULL
-tagged	NULL
fusion	NULL
protein	NULL
containing	NULL
sequences	NULL
corresponding	NULL
to	NULL
amino	NULL
acids	NULL
3-484	NULL
mapping	NULL
within	NULL
the	NULL
aminoterminal	NULL
two-thirds	NULL
of	NULL
BCL-6	NULL
of	NULL
human	NULL
origin	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

All	NULL
HD	NULL
cases	NULL
were	NULL
also	NULL
immunostained	NULL
for	NULL
the	NULL
following	NULL
antigens	NULL
:	NULL
CD3	NULL
(	NULL
DAKO-T3	NULL
and	NULL
polyclonal	NULL
anti-CD3	NULL
)	NULL
,	NULL
CD15	NULL
,	NULL
CD20	NULL
(	NULL
MoAb	NULL
L26	NULL
)	NULL
,	NULL
``	NULL
``	NULL
and	NULL
follicular	NULL
dendritic	NULL
cells	NULL
(	NULL
MoAb	NULL
R4/23	NULL
)	NULL
,	NULL
all	NULL
purchased	NULL
from	NULL
Dako	NULL
(	NULL
Glostrup	NULL
,	NULL
Denmark	NULL
)	NULL
;	NULL
CD4	NULL
(	NULL
MoAb	NULL
OKT4	NULL
;	NULL
Ortho	NULL
Diagnostic	NULL
System	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
)	NULL
;	NULL
CD79a	NULL
(	NULL
MoAb	NULL
mb-1	NULL
:	NULL
kindly	NULL
provided	NULL
by	NULL
D.Y	NULL
.	NULL

Mason	NULL
,	NULL
Oxford	NULL
,	NULL
UK	NULL
)	NULL
``	NULL
;	NULL
CD30	NULL
(	NULL
MoAb	NULL
Ber-H2	NULL
)	NULL
,	NULL
``	NULL
``	NULL
the	NULL
prolif-eration-associated	NULL
antigen	NULL
recognized	NULL
by	NULL
MoAb	NULL
Ki-67	NULL
``	NULL
``	NULL
;	NULL
and	NULL
CD57	NULL
(	NULL
MoAb	NULL
Leu-7	NULL
;	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

The	NULL
CD40L	NULL
was	NULL
detected	NULL
with	NULL
the	NULL
MoAb	NULL
M90	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
R.J.	NULL
Armitage	NULL
,	NULL
Immunex	NULL
R	NULL
&	NULL
D	NULL
Corp	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

Tissue	NULL
Samples	NULL
Immunohistological	NULL
studies	NULL
were	NULL
performed	NULL
on	NULL
41	NULL
HD	NULL
cases	NULL
(	NULL
19	NULL
NLPHD	NULL
,	NULL
12	NULL
NSHD	NULL
,	NULL
and	NULL
10	NULL
MCHD	NULL
)	NULL
that	NULL
were	NULL
classified	NULL
according	NULL
to	NULL
Rye	NULL
modification	NULL
of	NULL
the	NULL
Lukes	NULL
and	NULL
Butler	NULL
classification	NULL
.	NULL
``	NULL

'	NULL
Frozen	NULL
lymph	NULL
node	NULL
samples	NULL
were	NULL
available	NULL
in	NULL
36	NULL
cases	NULL
.	NULL

These	NULL
specimens	NULL
had	NULL
been	NULL
collected	NULL
during	NULL
the	NULL
period	NULL
between	NULL
1990	NULL
and	NULL
1994	NULL
and	NULL
were	NULL
stored	NULL
in	NULL
the	NULL
tissue	NULL
banks	NULL
of	NULL
Perugia	NULL
,	NULL
Bologna	NULL
and	NULL
Rome	NULL
Universities	NULL
and	NULL
the	NULL
Centro	NULL
di	NULL
Riferimento	NULL
Oncologico	NULL
,	NULL
Aviano	NULL
,	NULL
Italy	NULL
.	NULL

Paraffin	NULL
blocks	NULL
from	NULL
the	NULL
same	NULL
cases	NULL
were	NULL
also	NULL
available	NULL
for	NULL
immunohistologic	NULL
studies	NULL
.	NULL

Five	NULL
cases	NULL
of	NULL
NLPHD	NULL
could	NULL
only	NULL
be	NULL
studied	NULL
in	NULL
paraffin	NULL
sections	NULL
.	NULL

Tissue	NULL
Processing	NULL
Frozen	NULL
tissue	NULL
blocks	NULL
were	NULL
cut	NULL
in	NULL
a	NULL
cryostat	NULL
and	NULL
frozen	NULL
sections	NULL
(	NULL
5-um	NULL
thick	NULL
)	NULL
were	NULL
air-dried	NULL
overnight	NULL
,	NULL
fixed	NULL
in	NULL
acetone	NULL
for	NULL
10	NULL
minutes	NULL
,	NULL
and	NULL
either	NULL
immunostained	NULL
immediately	NULL
or	NULL
stored	NULL
at	NULL
-20°C	NULL
until	NULL
immunostaining	NULL
.	NULL
``	NULL

Paraffin	NULL
sections	NULL
were	NULL
cut	NULL
at	NULL
5	NULL
um	NULL
,	NULL
mounted	NULL
on	NULL
silane-coated	NULL
slides	NULL
,	NULL
and	NULL
dried	NULL
overnight	NULL
at	NULL
37°C	NULL
.	NULL

Sections	NULL
were	NULL
then	NULL
dewaxed	NULL
in	NULL
xylene	NULL
and	NULL
rehydrated	NULL
through	NULL
gradient	NULL
alcohols	NULL
.	NULL

Rehydrated	NULL
slides	NULL
were	NULL
placed	NULL
in	NULL
covered	NULL
glass	NULL
Coplin	NULL
jars	NULL
filled	NULL
with	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
buffer	NULL
,	NULL
pH	NULL
8.0	NULL
.	NULL

**	NULL
The	NULL
jars	NULL
were	NULL
incubated	NULL
three	NULL
times	NULL
for	NULL
5	NULL
minutes	NULL
at	NULL
700	NULL
W	NULL
in	NULL
a	NULL
De	NULL
Longhi	NULL
microwave	NULL
oven	NULL
.	NULL

After	NULL
microwave	NULL
irradia-tion	NULL
,	NULL
the	NULL
sections	NULL
were	NULL
allowed	NULL
to	NULL
cool	NULL
down	NULL
to	NULL
room	NULL
temperature	NULL
for	NULL
approximately	NULL
20	NULL
minutes	NULL
,	NULL
washed	NULL
with	NULL
Tris-buffered	NULL
saline	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
the	NULL
PG-B6p	NULL
MoAb	NULL
as	NULL
described	NULL
below	NULL
.	NULL

Single	NULL
and	NULL
Double	NULL
Immunoenzymatic	NULL
Staining	NULL
Labeling	NULL
of	NULL
frozen	NULL
and	NULL
paraffin	NULL
sections	NULL
with	NULL
MoAbs	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
immunoalkaline	NULL
phosphatase	NULL
(	NULL
APAAP	NULL
)	NULL
technique	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

The	NULL
polyclonal	NULL
anti-CD3	NULL
and	NULL
anti-BCL-6	NULL
antibodies	NULL
were	NULL
detected	NULL
by	NULL
a	NULL
four-stage	NULL
APAAP	NULL
technique	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

The	NULL
alkaline	NULL
phosphatase	NULL
reaction	NULL
was	NULL
shown	NULL
by	NULL
the	NULL
new	NULL
Fuchsin	NULL
substrate	NULL
.	NULL
``	NULL

The	NULL
endogenous	NULL
alkaline	NULL
phosphatase	NULL
was	NULL
blocked	NULL
by	NULL
adding	NULL
levamisole	NULL
to	NULL
the	NULL
substrate	NULL
solution	NULL
at	NULL
the	NULL
final	NULL
concentration	NULL
of	NULL
1	NULL
mmoV/L	NULL
.	NULL
``	NULL

Slides	NULL
were	NULL
then	NULL
counter-stained	NULL
for	NULL
5	NULL
minutes	NULL
in	NULL
Gill	NULL
's	NULL
hematoxylin	NULL
and	NULL
mounted	NULL
in	NULL
Kaiser	NULL
's	NULL
gelatin	NULL
.	NULL

Tissue	NULL
frozen	NULL
sections	NULL
from	NULL
10	NULL
cases	NULL
of	NULL
NLPHD	NULL
and	NULL
5	NULL
classical	NULL
HD	NULL
(	NULL
3	NULL
NSHD	NULL
and	NULL
2	NULL
MCHD	NULL
)	NULL
were	NULL
double-stained	NULL
for	NULL
the	NULL
following	NULL
pairs	NULL
of	NULL
antigens	NULL
:	NULL
BCL-6/CD30	NULL
,	NULL
BCL-6/CD20	NULL
,	NULL
BCL-6/CD3	NULL
,	NULL
and	NULL
BCL-6/CD57	NULL
.	NULL

Double	NULL
immunoenzymatic	NULL
labeling	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
the	NULL
PG-B6p	NULL
MoAb	NULL
was	NULL
detected	NULL
by	NULL
a	NULL
rabbit	NULL
antimouse	NULL
Ig	NULL
followed	NULL
by	NULL
mouse	NULL
PAP	NULL
complexes	NULL
(	NULL
both	NULL
purchased	NULL
from	NULL
Dako	NULL
)	NULL
.	NULL

After	NULL
three	NULL
washes	NULL
in	NULL
Tris-buffered	NULL
saline	NULL
,	NULL
FALINI	NULL
ET	NULL
AL	NULL
MoAbs	NULL
directed	NULL
against	NULL
the	NULL
second	NULL
pairs	NULL
of	NULL
antigens	NULL
were	NULL
applied	NULL
to	NULL
the	NULL
sections	NULL
and	NULL
detected	NULL
by	NULL
the	NULL
three-stage	NULL
APAAP	NULL
technique	NULL
,	NULL
``	NULL
``	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Assessment	NULL
of	NULL
BCL-6	NULL
Staining	NULL
in	NULL
HD	NULL
Samples	NULL
BCL-6	NULL
expression	NULL
in	NULL
neoplastic	NULL
cells	NULL
.	NULL

At	NULL
least	NULL
100	NULL
neoplastic	NULL
cells/per	NULL
section	NULL
,	NULL
as	NULL
defined	NULL
by	NULL
histologic	NULL
and	NULL
immunohistologic	NULL
criteria	NULL
(	NULL
positivity	NULL
for	NULL
CD30	NULL
)	NULL
,	NULL
were	NULL
counted	NULL
by	NULL
three	NULL
of	NULL
us	NULL
(	NULL
B.F.	NULL
,	NULL
S.P	NULL
.	NULL

,	NULL
and	NULL
LF	NULL
.	NULL
)	NULL

.	NULL

The	NULL
percentage	NULL
of	NULL
BCL-6*	NULL
neoplastic	NULL
cells	NULL
was	NULL
assigned	NULL
into	NULL
one	NULL
of	NULL
the	NULL
following	NULL
categories	NULL
:	NULL
0	NULL
,	NULL
less	NULL
than	NULL
10	NULL
%	NULL
,	NULL
10	NULL
%	NULL
to	NULL
25	NULL
%	NULL
,	NULL
25	NULL
%	NULL
to	NULL
50	NULL
%	NULL
,	NULL
50	NULL
%	NULL
to	NULL
75	NULL
%	NULL
,	NULL
and	NULL
greater	NULL
than	NULL
75	NULL
%	NULL
.	NULL

Only	NULL
definite	NULL
unambiguous	NULL
staining	NULL
on	NULL
unequivocal	NULL
malignant	NULL
cells	NULL
was	NULL
accepted	NULL
as	NULL
positive	NULL
.	NULL

The	NULL
distribution	NULL
(	NULL
nuclear	NULL
,	NULL
cytoplasmic	NULL
,	NULL
or	NULL
both	NULL
)	NULL
and	NULL
the	NULL
pattern	NULL
of	NULL
BCL-6	NULL
staining	NULL
(	NULL
speckled	NULL
v	NULL
diffuse	NULL
)	NULL
was	NULL
also	NULL
recorded	NULL
.	NULL

BCL-6	NULL
expression	NULL
in	NULL
the	NULL
reactive	NULL
T-cell	NULL
component	NULL
.	NULL

|	NULL
In	NULL
each	NULL
HD	NULL
sample	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
following	NULL
parameters	NULL
:	NULL
(	NULL
1	NULL
)	NULL
the	NULL
total	NULL
of	NULL
T	NULL
lymphocytes	NULL
showing	NULL
nuclear	NULL
expression	NULL
of	NULL
BCL-6	NULL
;	NULL
and	NULL
(	NULL
2	NULL
)	NULL
the	NULL
percentage	NULL
of	NULL
neoplastic	NULL
cells	NULL
ringed	NULL
by	NULL
BCL-6*	NULL
T	NULL
lymphocytes	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
three	NULL
to	NULL
five	NULL
representative	NULL
fields	NULL
were	NULL
examined	NULL
using	NULL
a	NULL
x25	NULL
objective	NULL
.	NULL

The	NULL
average	NULL
of	NULL
three	NULL
values	NULL
was	NULL
used	NULL
as	NULL
the	NULL
final	NULL
value	NULL
for	NULL
each	NULL
case	NULL
.	NULL

In	NULL
samples	NULL
of	NULL
NLPHD	NULL
and	NULL
NSHD	NULL
,	NULL
tumor	NULL
nodules	NULL
were	NULL
analyzed	NULL
.	NULL

In	NULL
cases	NULL
of	NULL
MCHD	NULL
that	NULL
showed	NULL
a	NULL
diffuse	NULL
archi-tecture	NULL
,	NULL
representative	NULL
fields	NULL
were	NULL
examined	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
percentage	NULL
of	NULL
neoplastic	NULL
cells	NULL
ringed	NULL
by	NULL
BCL-6*	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
counted	NULL
in	NULL
each	NULL
section	NULL
the	NULL
number	NULL
of	NULL
ringed	NULL
tumor	NULL
cells	NULL
and	NULL
the	NULL
total	NULL
number	NULL
of	NULL
tumor	NULL
cells	NULL
(	NULL
ringed	NULL
and	NULL
nonringed	NULL
)	NULL
and	NULL
determined	NULL
the	NULL
fraction	NULL
of	NULL
ringed	NULL
cells	NULL
over	NULL
the	NULL
total	NULL
.	NULL

Ten	NULL
high-power	NULL
fields	NULL
(	NULL
covering	NULL
5	NULL
tumor	NULL
nodules	NULL
in	NULL
NLPHD	NULL
and	NULL
NSHD	NULL
)	NULL
were	NULL
examined	NULL
in	NULL
each	NULL
case	NULL
.	NULL

A	NULL
ringed	NULL
tumor	NULL
cell	NULL
was	NULL
defined	NULL
as	NULL
one	NULL
in	NULL
which	NULL
greater	NULL
than	NULL
50	NULL
%	NULL
of	NULL
the	NULL
cell	NULL
's	NULL
circumference	NULL
was	NULL
occupied	NULL
by	NULL
BCL-6*	NULL
lymphocytes	NULL
.	NULL

The	NULL
staining	NULL
pattern	NULL
of	NULL
BCL-6	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
CD3	NULL
,	NULL
CD4	NULL
,	NULL
and	NULL
CD57	NULL
(	NULL
Leu7	NULL
)	NULL
molecules	NULL
(	NULL
assessed	NULL
according	NULL
to	NULL
the	NULL
above	NULL
criteria	NULL
in	NULL
serial	NULL
frozen	NULL
sections	NULL
)	NULL
.	NULL

In	NULL
10	NULL
NLPHD	NULL
and	NULL
5	NULL
classical	NULL
HD	NULL
,	NULL
double	NULL
immunoenzymatic	NULL
labeling	NULL
was	NULL
also	NULL
performed	NULL
to	NULL
confirm	NULL
the	NULL
findings	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
BCL-6	NULL
Protein	NULL
on	NULL
CD4O0L-Bearing	NULL
T	NULL
Cells	NULL
The	NULL
relationship	NULL
between	NULL
BCL-6	NULL
and	NULL
CD4OL	NULL
expression	NULL
was	NULL
studied	NULL
both	NULL
in	NULL
tissue	NULL
sections	NULL
of	NULL
HD	NULL
and	NULL
normal	NULL
activated	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
peripheral	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
from	NULL
normal	NULL
donors	NULL
were	NULL
purified	NULL
by	NULL
Ficoll-Hypaque	NULL
centrifugation	NULL
followed	NULL
by	NULL
negative	NULL
selection	NULL
with	NULL
anti-CD19	NULL
plus	NULL
anti-CD8	NULL
immunomagnetic	NULL
beads	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
,	NULL
``	NULL
and	NULL
activated	NULL
to	NULL
express	NULL
CDA4OL	NULL
by	NULL
exposure	NULL
to	NULL
TPA	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
1	NULL
pg/mL	NULL
)	NULL
for	NULL
8	NULL
hours	NULL
.	NULL
``	NULL

''	NULL
Purified	NULL
cells	NULL
were	NULL
assayed	NULL
by	NULL
flow	NULL
cytometry	NULL
for	NULL
expression	NULL
of	NULL
BCL-6	NULL
and	NULL
CD4O0L	NULL
.	NULL
``	NULL

To	NULL
detect	NULL
BCL-6	NULL
expression	NULL
,	NULL
cells	NULL
were	NULL
previously	NULL
fixed	NULL
in	NULL
4	NULL
%	NULL
paraformaldehyde	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
for	NULL
15	NULL
minutes	NULL
at	NULL
4°C	NULL
and	NULL
permealized	NULL
in	NULL
70	NULL
%	NULL
methanol	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
BCL-6	NULL
and	NULL
CD4O0L	NULL
(	NULL
MoAb	NULL
M90	NULL
)	NULL
in	NULL
CD4*	NULL
T	NULL
cells	NULL
was	NULL
also	NULL
studied	NULL
in	NULL
serial	NULL
frozen	NULL
sections	NULL
from	NULL
four	NULL
cases	NULL
of	NULL
NLPHD	NULL
.	NULL

A	NULL
subclone	NULL
of	NULL
the	NULL
Jurkat	NULL
human	NULL
T-cell	NULL
line	NULL
that	NULL
constitutively	NULL
express	NULL
the	NULL
CD4O0L®	NULL
served	NULL
as	NULL
positive	NULL
control	NULL
for	NULL
the	NULL
APAAP	NULL
immunostaining	NULL
procedure	NULL
.	NULL

RESULTS	NULL
BCL-6	NULL
Expression	NULL
in	NULL
NLPHD	NULL
BCL-6	NULL
expression	NULL
in	NULL
neoplastic	NULL
(	NULL
L	NULL
&	NULL
H	NULL
)	NULL
cells	NULL
.	NULL

A	NULL
summary	NULL
of	NULL
the	NULL
immunostaining	NULL
results	NULL
is	NULL
given	NULL
in	NULL
Tables	NULL
1	NULL
and	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BCL-6	NULL
EXPRESSION	NULL
IN	NULL
NLPHD	NULL
Table	NULL
1	NULL
.	NULL

BCL-6	NULL
Expression	NULL
in	NULL
Neoplastic	NULL
Cells	NULL
of	NULL
HD	NULL
Percentage	NULL
of	NULL
BCL-6*	NULL
Tumor	NULL
Cells	NULL
Histologic	NULL
Cases	NULL
Type	NULL
(	NULL
{	NULL
n	NULL
=	NULL
41	NULL
)	NULL
0	NULL
<	NULL
10	NULL
10-25	NULL
26-50	NULL
50-75	NULL
>	NULL
75	NULL
NLPHD	NULL
19	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
19*	NULL
NSHD	NULL
12	NULL
8	NULL
3t	NULL
-	NULL
1t	NULL
-	NULL
MCHD	NULL
10	NULL
7	NULL
2t	NULL
-	NULL
1t	NULL
-	NULL
®	NULL
Strong	NULL
positivity	NULL
in	NULL
most	NULL
neoplastic	NULL
cells	NULL
(	NULL
range	NULL
,	NULL
75	NULL
%	NULL
to	NULL
100	NULL
%	NULL
)	NULL
.	NULL

?	NULL

Weak	NULL
to	NULL
moderate	NULL
positivity	NULL
.	NULL

2	NULL
.	NULL

The	NULL
majority	NULL
of	NULL
neoplastic	NULL
(	NULL
L	NULL
&	NULL
H	NULL
)	NULL
cells	NULL
(	NULL
range	NULL
,	NULL
75	NULL
%	NULL
to	NULL
100	NULL
%	NULL
)	NULL
from	NULL
all	NULL
cases	NULL
of	NULL
NLPHD	NULL
showed	NULL
strong	NULL
nuclear	NULL
expression	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
(	NULL
Table	NULL
2	NULL
and	NULL
Fig	NULL
1A	NULL
through	NULL
E	NULL
)	NULL
.	NULL

The	NULL
nuclei	NULL
of	NULL
tumor	NULL
cells	NULL
appeared	NULL
homogeneously	NULL
positive	NULL
(	NULL
Fig	NULL
1B	NULL
,	NULL
D	NULL
,	NULL
and	NULL
E	NULL
)	NULL
;	NULL
there	NULL
was	NULL
no	NULL
evidence	NULL
of	NULL
cytoplasmic	NULL
labeling	NULL
.	NULL

The	NULL
nuclear	NULL
staining	NULL
pattern	NULL
of	NULL
tumor	NULL
cells	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
in	NULL
entrapped	NULL
secondary	NULL
follicles	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
difference	NULL
between	NULL
the	NULL
results	NULL
obtained	NULL
in	NULL
frozen	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
and	NULL
microwave-heated	NULL
paraffin	NULL
sections	NULL
stained	NULL
with	NULL
the	NULL
PG-B6p	NULL
MoAb	NULL
(	NULL
Fig	NULL
1D	NULL
and	NULL
E	NULL
)	NULL
.	NULL

The	NULL
strong	NULL
nuclear	NULL
positivity	NULL
of	NULL
neoplastic	NULL
cells	NULL
was	NULL
completely	NULL
abolished	NULL
by	NULL
preabsorbing	NULL
the	NULL
PG-B6	NULL
and	NULL
PG-B6p	NULL
supernatants	NULL
with	NULL
excess	NULL
GST-BCL-6	NULL
fusion	NULL
protein	NULL
that	NULL
was	NULL
used	NULL
as	NULL
immunogen	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
persistant	NULL
nuclear	NULL
staining	NULL
was	NULL
observed	NULL
when	NULL
the	NULL
antibodies	NULL
were	NULL
preabsorbed	NULL
with	NULL
an	NULL
unrelated	NULL
nuclear-associated	NULL
protein	NULL
(	NULL
PML	NULL
)	NULL
.	NULL

Results	NULL
comparable	NULL
to	NULL
those	NULL
reported	NULL
above	NULL
were	NULL
obtained	NULL
in	NULL
10	NULL
NLPHD	NULL
stained	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
anti-BCL-6	NULL
polyclonal	NULL
antibodies	NULL
N-70-6	NULL
and	NULL
N-3	NULL
.	NULL

However	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
labeling	NULL
was	NULL
lower	NULL
than	NULL
that	NULL
obtained	NULL
with	NULL
the	NULL
PG-B6	NULL
and	NULL
PG-B6p	NULL
MoAbs	NULL
.	NULL

BCL-6	NULL
expression	NULL
in	NULL
reactive	NULL
T	NULL
cells	NULL
.	NULL

-	NULL
Most	NULL
CD4*	NULL
T	NULL
cells	NULL
(	NULL
>	NULL
80	NULL
%	NULL
)	NULL
within	NULL
the	NULL
nodules	NULL
of	NULL
NLPHD	NULL
consistently	NULL
expressed	NULL
the	NULL
BCL-6	NULL
protein	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
only	NULL
occasional	NULL
scattered	NULL
BCL-6¢/CD4*	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
residual	NULL
internodular	NULL
T	NULL
areas	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Nuclear	NULL
expression	NULL
of	NULL
BCL-6	NULL
by	NULL
CD4*	NULL
T	NULL
cells	NULL
was	NULL
usually	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
and	NULL
was	NULL
more	NULL
clearly	NULL
seen	NULL
in	NULL
frozen	NULL
than	NULL
in	NULL
paraffin	NULL
sections	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
BCL-6+/CD4*	NULL
T	NULL
cells	NULL
in	NULL
NLPHD	NULL
were	NULL
clustered	NULL
around	NULL
areas	NULL
rich	NULL
in	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
and	NULL
frequently	NULL
formed	NULL
rosettes	NULL
around	NULL
them	NULL
(	NULL
Fig	NULL
1B	NULL
and	NULL
D	NULL
)	NULL
.	NULL

The	NULL
rosetting	NULL
phenomenon	NULL
was	NULL
striking	NULL
within	NULL
the	NULL
neoplastic	NULL
nodules	NULL
of	NULL
NLPHD	NULL
,	NULL
but	NULL
only	NULL
occasionally	NULL
occurred	NULL
in	NULL
the	NULL
paracortical	NULL
area	NULL
.	NULL

The	NULL
median	NULL
number	NULL
of	NULL
tumor	NULL
cells	NULL
ringed	NULL
by	NULL
BCL-6*	NULL
T	NULL
cells	NULL
was	NULL
50	NULL
%	NULL
in	NULL
NLPHD	NULL
(	NULL
v	NULL
<	NULL
5	NULL
%	NULL
in	NULL
classical	NULL
HD	NULL
)	NULL
.	NULL

In	NULL
all	NULL
NLPHD	NULL
cases	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
BCL-6+*	NULL
T	NULL
cells	NULL
rosetting	NULL
around	NULL
BCL-6+*	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
largely	NULL
outnumbered	NULL
that	NULL
of	NULL
CD57	NULL
(	NULL
Leu7	NULL
)	NULL
*	NULL
cells	NULL
.	NULL

BCL-6	NULL
Expression	NULL
in	NULL
Other	NULL
HD	NULL
Types	NULL
BCL-6	NULL
expression	NULL
in	NULL
neoplastic	NULL
cells	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
(	NULL
RS	NULL
)	NULL
cells	NULL
in	NULL
more	NULL
than	NULL
70	NULL
%	NULL
NSHD	NULL
and	NULL
MCHD	NULL
cases	NULL
were	NULL
BCL-6~	NULL
.	NULL

This	NULL
finding	NULL
was	NULL
not	NULL
due	NULL
to	NULL
diffusion	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
outside	NULL
the	NULL
nucleus	NULL
during	NULL
the	NULL
cryosectioning	NULL
procedure	NULL
,	NULL
because	NULL
other	NULL
nuclear-located	NULL
antigens	NULL
stained	NULL
in	NULL
parallel	NULL
(	NULL
eg	NULL
PML	NULL
and	NULL
Ki-67	NULL
)	NULL
were	NULL
467	NULL
strongly	NULL
expressed	NULL
on	NULL
tumor	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
staining	NULL
of	NULL
paraffin	NULL
sections	NULL
with	NULL
the	NULL
PG-B6p	NULL
MoAb	NULL
gave	NULL
the	NULL
same	NULL
results	NULL
.	NULL

BCL-6*	NULL
neoplastic	NULL
elements	NULL
were	NULL
present	NULL
in	NULL
about	NULL
30	NULL
%	NULL
cases	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
most	NULL
of	NULL
them	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
BCL-6*	NULL
tumor	NULL
cells	NULL
was	NULL
very	NULL
low	NULL
(	NULL
about	NULL
10	NULL
%	NULL
)	NULL
and	NULL
only	NULL
in	NULL
two	NULL
cases	NULL
ranged	NULL
between	NULL
25	NULL
%	NULL
and	NULL
50	NULL
%	NULL
(	NULL
Table	NULL
1	NULL
and	NULL
Fig	NULL
1F	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
apparent	NULL
correlation	NULL
between	NULL
BCL-6	NULL
expression	NULL
and	NULL
phenotype	NULL
of	NULL
tumor	NULL
cells	NULL
in	NULL
these	NULL
cases	NULL
(	NULL
6	NULL
null	NULL
and	NULL
1	NULL
B	NULL
)	NULL
.	NULL

BCL-6	NULL
expression	NULL
in	NULL
reactive	NULL
T	NULL
cells	NULL
.	NULL

Contrary	NULL
to	NULL
the	NULL
findings	NULL
observed	NULL
in	NULL
NLPHD	NULL
,	NULL
CD4*	NULL
T	NULL
cells	NULL
surrounding	NULL
Hodgkin	NULL
and	NULL
RS	NULL
cells	NULL
and	NULL
rosetting	NULL
around	NULL
them	NULL
in	NULL
cases	NULL
of	NULL
NSHD	NULL
and	NULL
MCHD	NULL
were	NULL
usually	NULL
BCL-6~	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Correlation	NULL
Between	NULL
BCL-6	NULL
and	NULL
CD4OL	NULL
Expression	NULL
The	NULL
finding	NULL
that	NULL
CD4*	NULL
T	NULL
cells	NULL
rosetting	NULL
around	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
of	NULL
NLPHD	NULL
tissues	NULL
consistently	NULL
express	NULL
BCL-6	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
the	NULL
relationship	NULL
between	NULL
the	NULL
expression	NULL
of	NULL
BCL-6	NULL
and	NULL
that	NULL
of	NULL
CD4OL	NULL
that	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
rosetting	NULL
phenomenon	NULL
observed	NULL
in	NULL
HD	NULL
tissues	NULL
.	NULL
``	NULL

The	NULL
expression	NULL
pattern	NULL
of	NULL
BCL-6	NULL
and	NULL
CD4O0L	NULL
by	NULL
CD4*	NULL
T	NULL
cells	NULL
in	NULL
frozen	NULL
sections	NULL
from	NULL
the	NULL
various	NULL
subtypes	NULL
of	NULL
HD	NULL
was	NULL
remarkably	NULL
different	NULL
.	NULL

Only	NULL
scattered	NULL
CD4OL+*	NULL
T	NULL
cells	NULL
were	NULL
found	NULL
in	NULL
the	NULL
tumor	NULL
nodules	NULL
of	NULL
NLPHD	NULL
,	NULL
which	NULL
conversely	NULL
contained	NULL
many	NULL
BCL-6+/CD4*	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
T	NULL
lymphocytes	NULL
rosetting	NULL
around	NULL
Hodgkin	NULL
and	NULL
RS	NULL
cells	NULL
of	NULL
NSHD	NULL
and	NULL
MCHD	NULL
were	NULL
usually	NULL
BCL-6~/CD40L	NULL
*	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Table	NULL
2	NULL
.	NULL

Expression	NULL
of	NULL
BCL-6	NULL
and	NULL
Other	NULL
Markers	NULL
in	NULL
Neoplastic	NULL
(	NULL
L	NULL
&	NULL
H	NULL
)	NULL
Cells	NULL
of	NULL
NLPHD	NULL
cog	NULL
CD20	NULL
Case	NULL
No	NULL
.	NULL

_	NULL
CD79a	NULL
-	NULL
CD30*	NULL
-	NULL
CD15	NULL
-	NULL
BCL-2	NULL
-	NULL
BCL-6t	NULL
-	NULL
BCL-6	NULL
Genet	NULL
1	NULL
+	NULL
+	NULL
-	NULL
-	NULL
+	NULL
G	NULL
2	NULL
+	NULL
+	NULL
-	NULL
-	NULL
+	NULL
G	NULL
3	NULL
+	NULL
+	NULL
-	NULL
-	NULL
+	NULL
G	NULL
4	NULL
+	NULL
+	NULL
-	NULL
-	NULL
+	NULL
G	NULL
5	NULL
+	NULL
+	NULL
-	NULL
-	NULL
+	NULL
G	NULL
6	NULL
+	NULL
+	NULL
-	NULL
-	NULL
+	NULL
ND	NULL
7	NULL
+	NULL
+	NULL
-	NULL
-	NULL
+	NULL
ND	NULL
8	NULL
+	NULL
+	NULL
-	NULL
-	NULL
+	NULL
ND	NULL
9	NULL
+	NULL
+	NULL
-	NULL
-	NULL
+	NULL
ND	NULL
10	NULL
+	NULL
+	NULL
-	NULL
ND	NULL
+	NULL
ND	NULL
11	NULL
+	NULL
+	NULL
-	NULL
ND	NULL
+	NULL
ND	NULL
12	NULL
+	NULL
+	NULL
-	NULL
ND	NULL
+	NULL
ND	NULL
13	NULL
+	NULL
*	NULL
-	NULL
ND	NULL
+	NULL
ND	NULL
14	NULL
+	NULL
*	NULL
-	NULL
ND	NULL
+	NULL
ND	NULL
15	NULL
+	NULL
+	NULL
-	NULL
ND	NULL
+	NULL
ND	NULL
16	NULL
+	NULL
-	NULL
-	NULL
ND	NULL
+	NULL
ND	NULL
17	NULL
+	NULL
-	NULL
-	NULL
ND	NULL
+	NULL
NO	NULL
18	NULL
+	NULL
+	NULL
-	NULL
ND	NULL
+	NULL
ND	NULL
19	NULL
+	NULL
-	NULL
-	NULL
ND	NULL
+	NULL
ND	NULL
Cases	NULL
no	NULL
.	NULL

1	NULL
through	NULL
14	NULL
were	NULL
immunostained	NULL
in	NULL
paraffin	NULL
and	NULL
cryostat	NULL
sections	NULL
.	NULL

Cases	NULL
15	NULL
through	NULL
19	NULL
had	NULL
only	NULL
paraffin	NULL
sections	NULL
available	NULL
for	NULL
study	NULL
.	NULL

Abbreviation	NULL
:	NULL
ND	NULL
,	NULL
not	NULL
done	NULL
.	NULL

*	NULL
Weak	NULL
(	NULL
+	NULL
)	NULL
to	NULL
strong	NULL
(	NULL
+	NULL
)	NULL
positivity	NULL
.	NULL

t	NULL
Range	NULL
of	NULL
positive	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
is	NULL
75	NULL
%	NULL
to	NULL
100	NULL
%	NULL
.	NULL

+	NULL
Assessed	NULL
by	NULL
Southern	NULL
blot	NULL
,	NULL
as	NULL
previously	NULL
described.©	NULL
In	NULL
all	NULL
cases	NULL
the	NULL
percentage	NULL
of	NULL
L	NULL
&	NULL
H	NULL
celis	NULL
was	NULL
less	NULL
than	NULL
5	NULL
%	NULL
.	NULL

From	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Fig	NULL
1	NULL
.	NULL

(	NULL
A	NULL
through	NULL
D	NULL
)	NULL
BCL-6	NULL
expression	NULL
in	NULL
NLPHD	NULL
(	NULL
lymph	NULL
node	NULL
biopsy	NULL
from	NULL
case	NULL
1	NULL
,	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
(	NULL
arrows	NULL
)	NULL
are	NULL
characteristically	NULL
surrounded	NULL
by	NULL
CD3*	NULL
rosetting	NULL
T	NULL
cells	NULL
(	NULL
paraffin	NULL
section	NULL
stained	NULL
with	NULL
anti-CD3	NULL
polyclonal	NULL
antibody	NULL
;	NULL
original	NULL
magnification	NULL
x	NULL
800	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Diffuse	NULL
nuclear	NULL
positivity	NULL
for	NULL
BCL-6	NULL
is	NULL
restricted	NULL
to	NULL
a	NULL
large	NULL
tumor	NULL
(	NULL
L	NULL
&	NULL
H	NULL
)	NULL
cell	NULL
(	NULL
long	NULL
arrow	NULL
)	NULL
bearing	NULL
B-cell	NULL
antigens	NULL
(	NULL
shown	NULL
in	NULL
C	NULL
)	NULL
and	NULL
to	NULL
nearby	NULL
reactive	NULL
T	NULL
cells	NULL
(	NULL
short	NULL
arrows	NULL
)	NULL
;	NULL
small	NULL
BCL-6~	NULL
cells	NULL
represent	NULL
IgD*/IgM*	NULL
lymphocytes	NULL
(	NULL
frozen	NULL
section	NULL
;	NULL
original	NULL
magnification	NULL
x	NULL
800	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Double	NULL
labeling	NULL
for	NULL
nuclear	NULL
BCL6	NULL
(	NULL
brown	NULL
)	NULL
and	NULL
surface	NULL
CD20	NULL
(	NULL
blue	NULL
)	NULL
.	NULL

The	NULL
tumor	NULL
nodule	NULL
is	NULL
composed	NULL
by	NULL
CD20*/BCL-6*	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
(	NULL
long	NULL
arrow	NULL
)	NULL
,	NULL
nearby	NULL
and	NULL
rosetting	NULL
T	NULL
cells	NULL
(	NULL
CD20~/	NULL
BCL-6*	NULL
)	NULL
,	NULL
and	NULL
CD20*/BCL-6~	NULL
B	NULL
cells	NULL
(	NULL
short	NULL
arrow	NULL
;	NULL
frozen	NULL
section	NULL
;	NULL
original	NULL
magnification	NULL
x	NULL
800	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Microwave-heated	NULL
paraffin	NULL
section	NULL
stained	NULL
with	NULL
the	NULL
PG-B6p	NULL
MoAb	NULL
.	NULL

Notice	NULL
a	NULL
BCL-6*	NULL
tumor	NULL
cell	NULL
(	NULL
long	NULL
arrow	NULL
)	NULL
ringed	NULL
by	NULL
BCL-6+	NULL
T	NULL
cells	NULL
(	NULL
short	NULL
arrows	NULL
;	NULL
original	NULL
magnification	NULL
x	NULL
600	NULL
)	NULL
.	NULL

(	NULL
E	NULL
)	NULL
NLPHD	NULL
(	NULL
case	NULL
5	NULL
,	NULL
Table	NULL
2	NULL
)	NULL
showing	NULL
a	NULL
strongly	NULL
BCL-6*	NULL
L	NULL
&	NULL
H	NULL
cell	NULL
against	NULL
a	NULL
background	NULL
of	NULL
BCL-6~	NULL
B	NULL
lymphocytes	NULL
(	NULL
paraffin	NULL
section	NULL
stained	NULL
with	NULL
PG-B6p	NULL
;	NULL
original	NULL
magnification	NULL
x	NULL
800	NULL
)	NULL
.	NULL

(	NULL
F	NULL
)	NULL
Mixed	NULL
cellularity	NULL
HD	NULL
(	NULL
lymph	NULL
node	NULL
frozen	NULL
section	NULL
)	NULL
.	NULL

Occasional	NULL
tumor	NULL
cells	NULL
(	NULL
long	NULL
arrow	NULL
)	NULL
show	NULL
nuclear	NULL
positivity	NULL
for	NULL
BCL-6	NULL
.	NULL

The	NULL
short	NULL
arrows	NULL
point	NULL
to	NULL
BCL-6~	NULL
tumor	NULL
cells	NULL
(	NULL
original	NULL
magnification	NULL
x	NULL
800	NULL
)	NULL
.	NULL

(	NULL
A	NULL
through	NULL
F	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
C	NULL
)	NULL
APAAP	NULL
technique	NULL
;	NULL
hematoxylin	NULL
counterstain	NULL
.	NULL

(	NULL
C	NULL
)	NULL
double	NULL
staining	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
;	NULL
hematoxylin	NULL
counterstain	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BCL-6	NULL
EXPRESSION	NULL
IN	NULL
NLPHD	NULL
469	NULL
BCL-6	NULL
CDA40L	NULL
T=	NULL
0	NULL
T=	NULL
12	NULL
Fig	NULL
2	NULL
.	NULL

Kinetic	NULL
study	NULL
of	NULL
BCL-6	NULL
and	NULL
CD4OL	NULL
expression	NULL
during	NULL
in	NULL
vitro	NULL
activation	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

Purified	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TPA	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
1	NULL
g/mL	NULL
)	NULL
for	NULL
12	NULL
,	NULL
24	NULL
,	NULL
and	NULL
T=	NULL
24	NULL
48	NULL
hours	NULL
.	NULL

The	NULL
abscissa	NULL
indicates	NULL
the	NULL
logarithm	NULL
of	NULL
the	NULL
relative	NULL
intensity	NULL
of	NULL
green	NULL
fluorescence	NULL
obtained	NULL
by	NULL
staining	NULL
cells	NULL
with	NULL
anti-BCL-6	NULL
and	NULL
anti-CD40L	NULL
MoAbs	NULL
(	NULL
thick	NULL
lines	NULL
)	NULL
and	NULL
isotype-matched	NULL
control	NULL
Igs	NULL
(	NULL
thin	NULL
lines	NULL
)	NULL
.	NULL

The	NULL
ordinate	NULL
indicates	NULL
relative	NULL
cell	NULL
num-bers	NULL
.	NULL

T=	NULL
48	NULL
In	NULL
keeping	NULL
with	NULL
these	NULL
immunohistologic	NULL
findings	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
BCL-6	NULL
and	NULL
CD4O0L	NULL
molecules	NULL
are	NULL
differently	NULL
regulated	NULL
during	NULL
in	NULL
vitro	NULL
activation	NULL
of	NULL
purified	NULL
normal	NULL
CD4*	NULL
T	NULL
cells	NULL
by	NULL
TPA	NULL
and	NULL
ionomycin	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

Less	NULL
than	NULL
5	NULL
%	NULL
of	NULL
resting	NULL
CD4*	NULL
T	NULL
cells	NULL
expressed	NULL
BCL-6	NULL
or	NULL
surface	NULL
CD4O0L	NULL
,	NULL
as	NULL
detected	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

After	NULL
activation	NULL
,	NULL
only	NULL
a	NULL
slight	NULL
increase	NULL
in	NULL
BCL-6*	NULL
T	NULL
cells	NULL
was	NULL
evidenced	NULL
,	NULL
with	NULL
a	NULL
peak	NULL
at	NULL
12	NULL
hours	NULL
,	NULL
when	NULL
25	NULL
%	NULL
of	NULL
cells	NULL
were	NULL
found	NULL
to	NULL
react	NULL
with	NULL
the	NULL
MoAb	NULL
PG-B6p	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
an	NULL
early	NULL
induction	NULL
of	NULL
CD40L	NULL
expression	NULL
was	NULL
observed	NULL
after	NULL
12	NULL
to	NULL
24	NULL
hours	NULL
of	NULL
activation	NULL
(	NULL
up	NULL
to	NULL
55	NULL
%	NULL
of	NULL
positive	NULL
cells	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
return	NULL
to	NULL
basal	NULL
levels	NULL
(	NULL
<	NULL
5	NULL
%	NULL
of	NULL
positive	NULL
cells	NULL
)	NULL
,	NULL
by	NULL
48	NULL
hours	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
provide	NULL
clear	NULL
immunohistologic	NULL
evidence	NULL
for	NULL
a	NULL
distinctive	NULL
BCL-6	NULL
expression	NULL
pattern	NULL
in	NULL
the	NULL
neoplastic	NULL
component	NULL
(	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
)	NULL
and	NULL
the	NULL
reactive	NULL
T-cell	NULL
background	NULL
of	NULL
NLPHD	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
NSHD	NULL
and	NULL
MCHD	NULL
subtypes	NULL
.	NULL

Strong	NULL
expression	NULL
of	NULL
BCL-6	NULL
in	NULL
tumor	NULL
cells	NULL
of	NULL
NLPHD	NULL
could	NULL
be	NULL
unequivocally	NULL
shown	NULL
by	NULL
immunocytochemical	NULL
labeling	NULL
of	NULL
paraffin	NULL
sections	NULL
with	NULL
the	NULL
PG-B6p	NULL
MoAb	NULL
and	NULL
by	NULL
double	NULL
immunoenzymatic	NULL
staining	NULL
showing	NULL
coexpression	NULL
of	NULL
CD20	NULL
,	NULL
CD30	NULL
,	NULL
and	NULL
BCL-6	NULL
in	NULL
tumor	NULL
(	NULL
L	NULL
&	NULL
H	NULL
)	NULL
cells	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
the	NULL
positivity	NULL
of	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
for	NULL
BCL-6	NULL
was	NULL
restricted	NULL
to	NULL
the	NULL
nuclei	NULL
with	NULL
a	NULL
diffuse/microgranular	NULL
pattern	NULL
.	NULL

A	NULL
number	NULL
of	NULL
findings	NULL
indicate	NULL
that	NULL
the	NULL
strong	NULL
expression	NULL
of	NULL
BCL-6	NULL
in	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
is	NULL
specific	NULL
.	NULL

Labeling	NULL
was	NULL
obtained	NULL
with	NULL
two	NULL
highly	NULL
specific	NULL
MoAbs	NULL
(	NULL
PG-B6	NULL
and	NULL
PG-B6p	NULL
)	NULL
both	NULL
directed	NULL
against	NULL
the	NULL
aminoterminal	NULL
portion	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
,	NULL
'	NULL
``	NULL
~	NULL
``	NULL
``	NULL
and	NULL
it	NULL
was	NULL
blocked	NULL
with	NULL
the	NULL
GST-BCL-6	NULL
fusion	NULL
protein	NULL
used	NULL
as	NULL
immunogen	NULL
.	NULL

The	NULL
possibility	NULL
that	NULL
the	NULL
positive	NULL
reaction	NULL
may	NULL
have	NULL
been	NULL
due	NULL
to	NULL
labeling	NULL
of	NULL
an	NULL
antigenic	NULL
epitope	NULL
shared	NULL
by	NULL
a	NULL
molecule	NULL
other	NULL
than	NULL
BCL-6	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
is	NULL
unlikely	NULL
,	NULL
because	NULL
the	NULL
same	NULL
immunostaining	NULL
pattern	NULL
A	NULL
A	NULL
A	NULL
A	NULL
was	NULL
obtained	NULL
with	NULL
the	NULL
MoAbs	NULL
PG-B6	NULL
and	NULL
PG-B6p	NULL
and	NULL
the	NULL
polyclonal	NULL
antibodies	NULL
N-70-6	NULL
and	NULL
N-3	NULL
,	NULL
all	NULL
of	NULL
which	NULL
appear	NULL
to	NULL
recognize	NULL
different	NULL
epitopes	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
.	NULL
``	NULL

NLPHD	NULL
markedly	NULL
differs	NULL
from	NULL
other	NULL
subtypes	NULL
of	NULL
HD	NULL
.	NULL
``	NULL

*	NULL
This	NULL
view	NULL
is	NULL
based	NULL
on	NULL
a	NULL
number	NULL
of	NULL
features	NULL
suggesting	NULL
that	NULL
NLPHD	NULL
may	NULL
represent	NULL
a	NULL
neoplasm	NULL
of	NULL
germinal	NULL
center	NULL
origin	NULL
:	NULL
(	NULL
1	NULL
)	NULL
the	NULL
ultrastructural	NULL
resemblance	NULL
of	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
to	NULL
centroblasts/large	NULL
noncleaved	NULL
cells	NULL
``	NULL
;	NULL
(	NULL
2	NULL
)	NULL
the	NULL
mature	NULL
B-cell	NULL
phenotype	NULL
of	NULL
neoplastic	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
(	NULL
CD19*	NULL
,	NULL
CD20*	NULL
,	NULL
CD22	NULL
,	NULL
J	NULL
chaint	NULL
,	NULL
CD79a+	NULL
)	NULL
``	NULL
*	NULL
``	NULL
``	NULL
;	NULL
(	NULL
3	NULL
)	NULL
the	NULL
occasional	NULL
expression	NULL
of	NULL
CD30	NULL
in	NULL
normal	NULL
and	NULL
neoplastic	NULL
centroblasts	NULL
``	NULL
;	NULL
(	NULL
4	NULL
)	NULL
the	NULL
close	NULL
association	NULL
of	NULL
tumor	NULL
cells	NULL
with	NULL
follicular	NULL
dendritic	NULL
cells	NULL
and	NULL
germinal	NULL
center	NULL
specific	NULL
T-helper	NULL
cells**	NULL
``	NULL
*	NULL
;	NULL
and	NULL
(	NULL
5	NULL
)	NULL
the	NULL
demonstration	NULL
by	NULL
single-cell	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
of	NULL
Ig	NULL
rearrangements	NULL
with	NULL
ongoing	NULL
somatic	NULL
mutations	NULL
of	NULL
V-regions	NULL
in	NULL
neoplastic	NULL
cells	NULL
.	NULL
``	NULL

Although	NULL
BCL-6	NULL
can	NULL
not	NULL
be	NULL
regarded	NULL
as	NULL
a	NULL
marker	NULL
specific	NULL
for	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
(	NULL
eg	NULL
,	NULL
a	NULL
subset	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
squamous	NULL
epithelial	NULL
cells	NULL
do	NULL
express	NULL
the	NULL
molecule	NULL
)	NULL
,	NULL
``	NULL
its	NULL
expression	NULL
in	NULL
NLPHD	NULL
provides	NULL
further	NULL
support	NULL
to	NULL
the	NULL
concept	NULL
that	NULL
this	NULL
disease	NULL
may	NULL
represent	NULL
a	NULL
neoplasm	NULL
of	NULL
germinal	NULL
center	NULL
origin	NULL
.	NULL

From	NULL
the	NULL
diagnostic	NULL
point	NULL
of	NULL
view	NULL
,	NULL
labeling	NULL
of	NULL
paraffin	NULL
sections	NULL
with	NULL
the	NULL
PG-B6p	NULL
MoAb	NULL
highlights	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
and	NULL
therefore	NULL
may	NULL
help	NULL
their	NULL
identification	NULL
.	NULL

Because	NULL
of	NULL
its	NULL
strong	NULL
and	NULL
consistent	NULL
expression	NULL
on	NULL
most	NULL
tumor	NULL
elements	NULL
of	NULL
NLPHD	NULL
,	NULL
BCL-6	NULL
could	NULL
well	NULL
substitute	NULL
EMA*	NULL
as	NULL
a	NULL
marker	NULL
for	NULL
special	NULL
studies	NULL
,	NULL
eg	NULL
,	NULL
picking-up	NULL
of	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
for	NULL
single	NULL
cell	NULL
PCR	NULL
analysis	NULL
in	NULL
paraffin	NULL
sections	NULL
.	NULL

``	NULL
``	NULL
*	NULL
'	NULL
Such	NULL
a	NULL
studies	NULL
should	NULL
allow	NULL
in	NULL
the	NULL
future	NULL
to	NULL
analyze	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
(	NULL
eg	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
mutations	NULL
)	NULL
*	NULL
in	NULL
isolated	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
.	NULL

A	NULL
small	NULL
percentage	NULL
of	NULL
Hodgkin	NULL
and	NULL
RS	NULL
cells	NULL
expressed	NULL
BCL-6	NULL
in	NULL
about	NULL
30	NULL
%	NULL
classical	NULL
HD	NULL
cases	NULL
with	NULL
no	NULL
apparent	NULL
correlation	NULL
with	NULL
the	NULL
phenotype	NULL
of	NULL
tumor	NULL
cells	NULL
(	NULL
null	NULL
v	NULL
B	NULL
v	NULL
T	NULL
)	NULL
.	NULL

The	NULL
biologic	NULL
significance	NULL
of	NULL
this	NULL
finding	NULL
is	NULL
presently	NULL
under	NULL
investigation	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

470	NULL
The	NULL
reactive	NULL
lymphoid	NULL
background	NULL
of	NULL
NLPHD	NULL
also	NULL
markedly	NULL
differs	NULL
from	NULL
that	NULL
of	NULL
other	NULL
types	NULL
of	NULL
HD	NULL
.	NULL
``	NULL

In	NULL
classical	NULL
HD	NULL
,	NULL
the	NULL
background	NULL
of	NULL
nonneoplastic	NULL
lymphocytes	NULL
is	NULL
constituted	NULL
by	NULL
CD4*	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
nodules	NULL
of	NULL
NLPHD	NULL
are	NULL
mainly	NULL
made	NULL
up	NULL
of	NULL
B	NULL
cells	NULL
displaying	NULL
the	NULL
phenotype	NULL
of	NULL
primary	NULL
B	NULL
follicles	NULL
(	NULL
IgD*/IgM*	NULL
)	NULL
admixed	NULL
with	NULL
a	NULL
variable	NULL
percentage	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
provide	NULL
the	NULL
first	NULL
immunohistologic	NULL
evidence	NULL
that	NULL
the	NULL
BCL-6*/CD40L~	NULL
phenotype	NULL
is	NULL
a	NULL
feature	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
in	NULL
tissues	NULL
involved	NULL
by	NULL
NLPHD	NULL
,	NULL
as	NULL
opposed	NULL
to	NULL
CD4*	NULL
T	NULL
cells	NULL
in	NULL
other	NULL
HD	NULL
subtypes	NULL
that	NULL
consistently	NULL
express	NULL
CD40L	NULL
``	NULL
'	NULL
but	NULL
lack	NULL
BCL-6	NULL
.	NULL

In	NULL
all	NULL
NLPHD	NULL
cases	NULL
studied	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
BCL-6¢/CD4*	NULL
T	NULL
cells	NULL
largely	NULL
outnumbered	NULL
that	NULL
of	NULL
CD57	NULL
(	NULL
Leu7	NULL
)	NULL
*	NULL
cells	NULL
,	NULL
which	NULL
is	NULL
commonly	NULL
regarded	NULL
as	NULL
a	NULL
distinguishing	NULL
immunophenotypic	NULL
feature	NULL
of	NULL
NLPHD	NULL
.	NULL

``	NULL
**	NULL
``	NULL
These	NULL
immunohistologic	NULL
findings	NULL
raise	NULL
questions	NULL
regarding	NULL
the	NULL
biologic	NULL
significance	NULL
of	NULL
BCL-6°/CD4*	NULL
T	NULL
cells	NULL
in	NULL
NLPHD	NULL
.	NULL

We	NULL
recently	NULL
found	NULL
that	NULL
,	NULL
in	NULL
normal	NULL
lymphoid	NULL
tissues	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
,	NULL
BCL-6	NULL
is	NULL
also	NULL
expressed	NULL
by	NULL
a	NULL
small	NULL
subset	NULL
of	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
that	NULL
are	NULL
present	NULL
in	NULL
higher	NULL
percentage	NULL
in	NULL
germinal	NULL
centers	NULL
than	NULL
in	NULL
the	NULL
interfollicular	NULL
areas	NULL
(	NULL
5	NULL
%	NULL
to	NULL
10	NULL
%	NULL
v	NULL
0.5	NULL
%	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL
``	NULL

Whether	NULL
these	NULL
cells	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
T-cell-mediated	NULL
germinal	NULL
center-related	NULL
functions	NULL
``	NULL
will	NULL
require	NULL
further	NULL
studies	NULL
on	NULL
isolated	NULL
germinal	NULL
center	NULL
cells	NULL
.	NULL

Notably	NULL
,	NULL
BCL-6¢/CD4*	NULL
reactive	NULL
T	NULL
cells	NULL
were	NULL
only	NULL
found	NULL
within	NULL
the	NULL
tumor	NULL
nodules	NULL
of	NULL
NLPHD	NULL
,	NULL
eg	NULL
,	NULL
nearby	NULL
to	NULL
or	NULL
intimately	NULL
associated	NULL
with	NULL
neoplastic	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
residual	NULL
internodular	NULL
T	NULL
areas	NULL
were	NULL
often	NULL
occupied	NULL
by	NULL
CD3	NULL
¢/CD4*/BCLG6_	NULL
T	NULL
lymphocytes	NULL
.	NULL

This	NULL
topographic	NULL
distribution	NULL
suggests	NULL
that	NULL
BCL-6	NULL
expression	NULL
by	NULL
T	NULL
cells	NULL
in	NULL
NLPHD	NULL
is	NULL
strictly	NULL
dependent	NULL
on	NULL
closeness	NULL
to	NULL
neoplastic	NULL
B	NULL
cells	NULL
(	NULL
so-called	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
)	NULL
,	NULL
possibly	NULL
reflecting	NULL
in	NULL
situ	NULL
release	NULL
of	NULL
cytokines	NULL
by	NULL
tumor	NULL
cells	NULL
or	NULL
cell-contact-de-pendent	NULL
interactions	NULL
that	NULL
could	NULL
induce	NULL
expression	NULL
of	NULL
BCL-6	NULL
or	NULL
viceversa	NULL
.	NULL

However	NULL
,	NULL
the	NULL
results	NULL
of	NULL
our	NULL
immunohistologic	NULL
studies	NULL
and	NULL
the	NULL
flow	NULL
cytometry	NULL
finding	NULL
that	NULL
BCL-6	NULL
and	NULL
CD4O0L	NULL
are	NULL
differently	NULL
regulated	NULL
during	NULL
the	NULL
in	NULL
vitro	NULL
activation	NULL
of	NULL
normal	NULL
CD4*	NULL
T	NULL
cells	NULL
lend	NULL
no	NULL
support	NULL
for	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
link	NULL
between	NULL
the	NULL
expression	NULL
of	NULL
BCL-6	NULL
and	NULL
that	NULL
of	NULL
CD4OL	NULL
that	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
rosetting	NULL
phenomenon	NULL
in	NULL
HD	NULL
tissues	NULL
.	NULL
``	NULL

''	NULL
'	NULL
In	NULL
conclusion	NULL
,	NULL
labeling	NULL
for	NULL
BCL-6	NULL
provides	NULL
another	NULL
marker	NULL
for	NULL
characterizing	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
and	NULL
the	NULL
lymphoid	NULL
mi-croenvironment	NULL
of	NULL
NLPHD	NULL
.	NULL

The	NULL
immunohistologic	NULL
finding	NULL
of	NULL
strongly	NULL
BCL-6*	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
surrounded	NULL
and/or	NULL
ringed	NULL
by	NULL
BCL-6+/CD4*	NULL
T	NULL
cells	NULL
against	NULL
a	NULL
background	NULL
of	NULL
BCL-6~-/	NULL
IgM*/IgD*	NULL
B	NULL
lymphocytes	NULL
in	NULL
the	NULL
tumor	NULL
nodules	NULL
of	NULL
NLPHD	NULL
is	NULL
so	NULL
typical	NULL
it	NULL
that	NULL
immediately	NULL
allows	NULL
recognition	NULL
of	NULL
this	NULL
pathologic	NULL
entity	NULL
.	NULL

Whether	NULL
these	NULL
immunohistologic	NULL
features	NULL
may	NULL
be	NULL
of	NULL
value	NULL
for	NULL
differentiating	NULL
NLPHD	NULL
from	NULL
cases	NULL
of	NULL
T-cell-rich	NULL
B-cell	NULL
lymphoma	NULL
should	NULL
be	NULL
the	NULL
goal	NULL
of	NULL
future	NULL
studies	NULL
.	NULL

Better	NULL
understanding	NULL
of	NULL
the	NULL
biological	NULL
function	NULL
(	NULL
s	NULL
)	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
may	NULL
be	NULL
expected	NULL
to	NULL
shed	NULL
further	NULL
light	NULL
on	NULL
the	NULL
pathogenesis	NULL
of	NULL
NLPHD	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Gisberto	NULL
Loreti	NULL
and	NULL
Laura	NULL
Natali-Tanci	NULL
for	NULL
the	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

FALINI	NULL
ET	NULL
AL	NULL
REFERENCES	NULL
1	NULL
.	NULL

Offit	NULL
K	NULL
,	NULL
Jhanwar	NULL
S	NULL
,	NULL
Ebrahim	NULL
SA	NULL
,	NULL
Filippa	NULL
D	NULL
,	NULL
Clarkson	NULL
BD	NULL
,	NULL
Chaganti	NULL
RSK	NULL
:	NULL
t	NULL
(	NULL
3	NULL
;	NULL
22	NULL
)	NULL
(	NULL
q27.q11	NULL
)	NULL
;	NULL
A	NULL
novel	NULL
translocation	NULL
associated	NULL
with	NULL
diffuse	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
.	NULL

Blood	NULL
74:1876	NULL
,	NULL
1989	NULL
2	NULL
.	NULL

Bastard	NULL
C	NULL
,	NULL
Tilly	NULL
H	NULL
,	NULL
Lenormand	NULL
B	NULL
,	NULL
Bigorgne	NULL
C	NULL
,	NULL
Boulet	NULL
D	NULL
,	NULL
Kunlin	NULL
A	NULL
,	NULL
Moncond	NULL
M	NULL
,	NULL
Piguet	NULL
H	NULL
:	NULL
Translocations	NULL
involving	NULL
band	NULL
3q27	NULL
and	NULL
Ig	NULL
gene	NULL
regions	NULL
in	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
.	NULL

Blood	NULL
79:2527	NULL
,	NULL
1992	NULL
3	NULL
.	NULL

Ye	NULL
BH	NULL
,	NULL
Rao	NULL
PH	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Cloning	NULL
of	NULL
bet-6	NULL
,	NULL
the	NULL
locus	NULL
involved	NULL
in	NULL
chromosome	NULL
translocations	NULL
affecting	NULL
band	NULL
3q27	NULL
in	NULL
B-cell	NULL
lymphoma	NULL
.	NULL

Cancer	NULL
Res	NULL
53:2732	NULL
,	NULL
1993	NULL
4	NULL
.	NULL

Baron	NULL
BW	NULL
,	NULL
Nucifora	NULL
G	NULL
,	NULL
McCabe	NULL
N	NULL
,	NULL
Espinosa	NULL
R	NULL
III	NULL
,	NULL
Le	NULL
Beau	NULL
MM	NULL
,	NULL
McKeithan	NULL
TW	NULL
:	NULL
Identification	NULL
of	NULL
the	NULL
gene	NULL
associated	NULL
with	NULL
the	NULL
recurring	NULL
chromosomal	NULL
translocations	NULL
t	NULL
(	NULL
3	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q27	NULL
;	NULL
q32	NULL
)	NULL
and	NULL
t	NULL
(	NULL
3	NULL
;	NULL
22	NULL
)	NULL
(	NULL
q27	NULL
;	NULL
q11	NULL
)	NULL
in	NULL
B-cell	NULL
lymphomas	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:5262	NULL
,	NULL
1992	NULL
5	NULL
.	NULL

Ye	NULL
BH	NULL
,	NULL
Lista	NULL
F	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Offit	NULL
K	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla	NULL
Favera	NULL
R	NULL
:	NULL
Alterations	NULL
of	NULL
a	NULL
zinc	NULL
finger-encoding	NULL
gene	NULL
,	NULL
BCL6	NULL
,	NULL
in	NULL
diffuse	NULL
large-cell	NULL
lymphoma	NULL
.	NULL

Science	NULL
262:747	NULL
,	NULL
1993	NULL
6	NULL
.	NULL

Offit	NULL
K	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Louie	NULL
DC	NULL
,	NULL
Parsa	NULL
NZ	NULL
,	NULL
Leung	NULL
D	NULL
,	NULL
Portlock	NULL
C	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Lista	NULL
F	NULL
,	NULL
Filippa	NULL
D	NULL
,	NULL
Rosenbaum	NULL
A	NULL
,	NULL
Ladanyi	NULL
M	NULL
,	NULL
Jhanwar	NULL
S	NULL
,	NULL
Dalla	NULL
Favera	NULL
R	NULL
,	NULL
Shaganti	NULL
RSK	NULL
:	NULL
Rearrangement	NULL
of	NULL
the	NULL
BCL6	NULL
gene	NULL
as	NULL
a	NULL
prognostic	NULL
marker	NULL
in	NULL
diffuse	NULL
large	NULL
cell	NULL
lymphoma	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
331:74	NULL
,	NULL
1994	NULL
7	NULL
.	NULL

El-Baradi	NULL
T	NULL
,	NULL
Pieler	NULL
T	NULL
:	NULL
Zinc	NULL
finger	NULL
proteins	NULL
:	NULL
What	NULL
we	NULL
know	NULL
and	NULL
what	NULL
we	NULL
would	NULL
like	NULL
to	NULL
know	NULL
.	NULL

Mech	NULL
Dev	NULL
35:155	NULL
,	NULL
1991	NULL
8	NULL
.	NULL

Chen	NULL
Z	NULL
,	NULL
Brand	NULL
NJ	NULL
,	NULL
Chen	NULL
A	NULL
,	NULL
Chen	NULL
SJ	NULL
,	NULL
Tong	NULL
JH	NULL
,	NULL
Wang	NULL
ZY	NULL
,	NULL
Waxman	NULL
S	NULL
,	NULL
Zelent	NULL
A	NULL
:	NULL
Fusion	NULL
between	NULL
a	NULL
novel	NULL
Kruppel-like	NULL
finger	NULL
gene	NULL
and	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor-a	NULL
locus	NULL
due	NULL
to	NULL
a	NULL
variant	NULL
t	NULL
(	NULL
11	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
associated	NULL
with	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

EMBO	NULL
J	NULL
12	NULL
;	NULL
1161	NULL
,	NULL
1993	NULL
9	NULL
.	NULL

Cattoretti	NULL
G	NULL
,	NULL
Chang	NULL
C-C	NULL
,	NULL
Cechova	NULL
K	NULL
,	NULL
Zhang	NULL
J	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Louie	NULL
DC	NULL
,	NULL
Offit	NULL
K	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla	NULL
Favera	NULL
R	NULL
:	NULL
The	NULL
BCL-6	NULL
protein	NULL
is	NULL
expressed	NULL
in	NULL
germinal-center	NULL
B	NULL
cells	NULL
.	NULL

Blood	NULL
86:45	NULL
,	NULL
1995	NULL
10	NULL
.	NULL

Onizuka	NULL
T	NULL
,	NULL
Moriyama	NULL
M	NULL
,	NULL
Yamochi	NULL
T	NULL
,	NULL
Kuroda	NULL
T	NULL
,	NULL
Kazama	NULL
A	NULL
,	NULL
Kanazawa	NULL
N	NULL
,	NULL
Sato	NULL
K	NULL
,	NULL
Kato	NULL
H	NULL
,	NULL
Mori	NULL
S	NULL
:	NULL
BCL-6	NULL
gene	NULL
product	NULL
,	NULL
a	NULL
92-to	NULL
98-kD	NULL
nuclear	NULL
phosphoprotein	NULL
,	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
and	NULL
their	NULL
neoplastic	NULL
counterparts	NULL
.	NULL

Blood	NULL
86:28	NULL
,	NULL
1995	NULL
11	NULL
.	NULL

Flenghi	NULL
L	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Fizzotti	NULL
M	NULL
,	NULL
Bigemna	NULL
B	NULL
,	NULL
Cattoretti	NULL
G	NULL
,	NULL
Venturi	NULL
S	NULL
,	NULL
Pacini	NULL
R	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Pescarmona	NULL
E	NULL
,	NULL
Pelicci	NULL
P-G	NULL
,	NULL
Dalla	NULL
Favera	NULL
R	NULL
,	NULL
Falini	NULL
B	NULL
:	NULL
A	NULL
specific	NULL
monoclonal	NULL
antibody	NULL
(	NULL
PG-B6	NULL
)	NULL
detects	NULL
expression	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
in	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
147:405	NULL
,	NULL
1995	NULL
12	NULL
.	NULL

Ye	NULL
BH	NULL
,	NULL
Chaganti	NULL
S	NULL
,	NULL
Chang	NULL
C-C	NULL
,	NULL
Niu	NULL
H	NULL
,	NULL
Corradini	NULL
P	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla	NULL
Favera	NULL
R	NULL
:	NULL
Chromosomal	NULL
translocations	NULL
cause	NULL
deregulated	NULL
BCL-6	NULL
expression	NULL
by	NULL
promoter	NULL
substitution	NULL
in	NULL
B-cell	NULL
lymphoma	NULL
.	NULL

EMBO	NULL
J	NULL
(	NULL
in	NULL
press	NULL
)	NULL
13	NULL
.	NULL

Mason	NULL
DY	NULL
,	NULL
Banks	NULL
PM	NULL
,	NULL
Chan	NULL
JKC	NULL
,	NULL
Cleary	NULL
ML	NULL
,	NULL
Delsol	NULL
G	NULL
,	NULL
De	NULL
Wolf	NULL
Peeters	NULL
C	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Gatter	NULL
KC	NULL
,	NULL
Grogan	NULL
TM	NULL
,	NULL
Harris	NULL
NL	NULL
,	NULL
Isaacson	NULL
P	NULL
,	NULL
Jaffe	NULL
E	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Muller-Hermelink	NULL
HK	NULL
,	NULL
Pileri	NULL
SA	NULL
,	NULL
Piris	NULL
MA	NULL
,	NULL
Ralfkier	NULL
E	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
Warnke	NULL
RA	NULL
:	NULL
Nodular	NULL
lymphocyte	NULL
predominance	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

A	NULL
distinct	NULL
clinicopathologic	NULL
entity	NULL
.	NULL

Am	NULL
J	NULL
Surg	NULL
Pathol	NULL
18:526	NULL
,	NULL
1994	NULL
14	NULL
.	NULL

Harris	NULL
NL	NULL
,	NULL
Jaffe	NULL
ES	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
Banks	NULL
PM	NULL
,	NULL
Chan	NULL
JKC	NULL
,	NULL
Cleary	NULL
ML	NULL
,	NULL
Delsol	NULL
G	NULL
,	NULL
De	NULL
Wolf	NULL
Peeters	NULL
C	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Gatter	NULL
KC	NULL
,	NULL
Grogan	NULL
TM	NULL
,	NULL
Isaacson	NULL
P	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Mason	NULL
DY	NULL
,	NULL
Muller-Hermelink	NULL
HK	NULL
,	NULL
Pileri	NULL
SA	NULL
,	NULL
Piris	NULL
MA	NULL
,	NULL
Ralfkier	NULL
E	NULL
,	NULL
Warnke	NULL
RA	NULL
:	NULL
A	NULL
revised	NULL
European-American	NULL
classification	NULL
of	NULL
lymphoid	NULL
neoplasms	NULL
:	NULL
A	NULL
proposal	NULL
from	NULL
the	NULL
International	NULL
Lymphoma	NULL
Study	NULL
Group	NULL
.	NULL

Blood	NULL
84:1361	NULL
,	NULL
1994	NULL
15	NULL
.	NULL

Haluska	NULL
F	NULL
,	NULL
Brufsky	NULL
AM	NULL
,	NULL
Canellos	NULL
GF	NULL
:	NULL
The	NULL
cellular	NULL
biology	NULL
of	NULL
the	NULL
Reed-Sternberg	NULL
cells	NULL
.	NULL

Blood	NULL
84:1005	NULL
,	NULL
1994	NULL
16	NULL
.	NULL

Flenghi	NULL
L	NULL
,	NULL
Fizzotti	NULL
M	NULL
,	NULL
Bigerna	NULL
B	NULL
,	NULL
Cattoretti	NULL
G	NULL
,	NULL
Venturi	NULL
S	NULL
,	NULL
Pasqualucei	NULL
L	NULL
,	NULL
Pacini	NULL
R	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Gambacorta	NULL
M	NULL
,	NULL
Baroni	NULL
C	NULL
,	NULL
Pescarmona	NULL
E	NULL
,	NULL
Pelicci	NULL
P-G	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
,	NULL
Falini	NULL
B	NULL
:	NULL
Monoclonal	NULL
antibod-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BCL-6	NULL
EXPRESSION	NULL
IN	NULL
NLPHD	NULL
ies	NULL
PG-B6a	NULL
and	NULL
PG-Bop	NULL
recognize	NULL
respectively	NULL
a	NULL
highly	NULL
evolutionary	NULL
conserved	NULL
and	NULL
formol-resistant	NULL
epitope	NULL
on	NULL
the	NULL
aminoterminal	NULL
region	NULL
of	NULL
the	NULL
human	NULL
BCL-6	NULL
protein	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
(	NULL
in	NULL
press	NULL
)	NULL
17	NULL
.	NULL

Mason	NULL
DY	NULL
,	NULL
Comans-Bitter	NULL
WM	NULL
,	NULL
Cordell	NULL
JL	NULL
,	NULL
Verhoeven	NULL
MJ	NULL
,	NULL
van	NULL
Dongen	NULL
JJM	NULL
:	NULL
Antibody	NULL
L26	NULL
recognizes	NULL
an	NULL
intracellular	NULL
epitope	NULL
on	NULL
the	NULL
B-cell	NULL
associated	NULL
antigen	NULL
CD20	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
136:1215	NULL
,	NULL
1990	NULL
18	NULL
.	NULL

Mason	NULL
DY	NULL
,	NULL
Cordell	NULL
JL	NULL
,	NULL
Tse	NULL
AGD	NULL
,	NULL
Van	NULL
Dongen	NULL
JJM	NULL
,	NULL
Van	NULL
Noesel	NULL
CJM	NULL
,	NULL
Micklem	NULL
K	NULL
,	NULL
Pulford	NULL
K	NULL
,	NULL
Valensi	NULL
F	NULL
,	NULL
Comans-Bitter	NULL
WM	NULL
,	NULL
Borst	NULL
J	NULL
,	NULL
Gatter	NULL
KC	NULL
:	NULL
The	NULL
IgM	NULL
associated	NULL
protein	NULL
mb-1	NULL
as	NULL
a	NULL
marker	NULL
of	NULL
normal	NULL
and	NULL
neoplastic	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
147:2474	NULL
,	NULL
1991	NULL
19	NULL
.	NULL

Schwarting	NULL
R	NULL
,	NULL
Gerdes	NULL
J	NULL
,	NULL
Durkop	NULL
H	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Stein	NULL
H	NULL
:	NULL
Ber-H2	NULL
:	NULL
A	NULL
new	NULL
anti	NULL
Ki-1	NULL
(	NULL
CD30	NULL
)	NULL
monoclonal	NULL
antibody	NULL
directed	NULL
at	NULL
a	NULL
formol-resistant	NULL
epitope	NULL
.	NULL

Blood	NULL
74:1678	NULL
,	NULL
1989	NULL
20	NULL
.	NULL

Gerdes	NULL
J	NULL
,	NULL
Li	NULL
L	NULL
,	NULL
Schlueter	NULL
C	NULL
,	NULL
Duchrow	NULL
M	NULL
,	NULL
Wohlenberg	NULL
C	NULL
,	NULL
Gerlach	NULL
C	NULL
,	NULL
Stahmer	NULL
I	NULL
,	NULL
Kloth	NULL
S	NULL
,	NULL
Brandt	NULL
E	NULL
,	NULL
Flad	NULL
HD	NULL
:	NULL
Immunobiochem-ical	NULL
and	NULL
molecular	NULL
biologic	NULL
characterization	NULL
of	NULL
the	NULL
cell	NULL
proliferation-associated	NULL
nuclear	NULL
antigen	NULL
that	NULL
is	NULL
defined	NULL
by	NULL
monoclonal	NULL
antibody	NULL
Ki-67	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
138:1359	NULL
,	NULL
1993	NULL
21	NULL
.	NULL

Lukes	NULL
RJ	NULL
,	NULL
Butler	NULL
JJ	NULL
:	NULL
The	NULL
pathology	NULL
and	NULL
nomenclature	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Cancer	NULL
Res	NULL
26:1063	NULL
,	NULL
1966	NULL
22	NULL
.	NULL

Falini	NULL
B	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Martelli	NULL
MF	NULL
:	NULL
Histological	NULL
and	NULL
immunohistological	NULL
analysis	NULL
of	NULL
human	NULL
lymphomas	NULL
.	NULL

Crit	NULL
Rev	NULL
Oncol	NULL
Hematol	NULL
9:305	NULL
,	NULL
1989	NULL
23	NULL
.	NULL

Mason	NULL
DY	NULL
,	NULL
Erber	NULL
MN	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
Gatter	NULL
KC	NULL
:	NULL
Immunoenzymatic	NULL
labelling	NULL
of	NULL
hematological	NULL
samples	NULL
with	NULL
monoclonal	NULL
antibodies	NULL
,	NULL
in	NULL
Beverley	NULL
PCL	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Methods	NULL
in	NULL
Haematology	NULL
,	NULL
vol	NULL
13	NULL
.	NULL

London	NULL
,	NULL
UK	NULL
,	NULL
Churchill-Livingstone	NULL
,	NULL
1989	NULL
,	NULL
p	NULL
145	NULL
24	NULL
.	NULL

Morgan	NULL
JM	NULL
,	NULL
Navabi	NULL
H	NULL
,	NULL
Schmid	NULL
KW	NULL
,	NULL
Jasani	NULL
B	NULL
:	NULL
Possible	NULL
role	NULL
of	NULL
tissue-bound	NULL
calcium	NULL
ions	NULL
in	NULL
citrate-mediated	NULL
high-temperature	NULL
antigen	NULL
retrieval	NULL
.	NULL

J	NULL
Pathol	NULL
174:301	NULL
,	NULL
1994	NULL
25	NULL
.	NULL

Cordell	NULL
JL	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Erber	NULL
WN	NULL
,	NULL
Ghosh	NULL
AK	NULL
,	NULL
Abdulaziz	NULL
Z	NULL
,	NULL
MacDonald	NULL
S	NULL
,	NULL
Pulford	NULL
KAF	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
Mason	NULL
DY	NULL
:	NULL
Immunoenzymatic	NULL
labelling	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
using	NULL
immune	NULL
complexes	NULL
of	NULL
alkaline	NULL
phosphatase	NULL
and	NULL
monoclonal	NULL
anti-alkaline	NULL
phosphatase	NULL
(	NULL
APAAP	NULL
complexes	NULL
)	NULL
.	NULL

J	NULL
Histochem	NULL
Cytochem	NULL
32:219	NULL
,	NULL
1984	NULL
26	NULL
.	NULL

Flenghi	NULL
L	NULL
,	NULL
Fagioli	NULL
M	NULL
,	NULL
Tomassoni	NULL
L	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Gambacorta	NULL
M	NULL
,	NULL
Pacini	NULL
R	NULL
,	NULL
Grignani	NULL
F	NULL
,	NULL
Casini	NULL
T	NULL
,	NULL
Ferrucci	NULL
PF	NULL
,	NULL
Martelli	NULL
MF	NULL
,	NULL
Pelicci	NULL
PG	NULL
,	NULL
Falini	NULL
B	NULL
:	NULL
Characterization	NULL
of	NULL
a	NULL
new	NULL
monoclonal	NULL
antibody	NULL
(	NULL
PG-M3	NULL
)	NULL
directed	NULL
against	NULL
the	NULL
aminoterminal	NULL
portion	NULL
of	NULL
the	NULL
PML	NULL
gene	NULL
product	NULL
:	NULL
Immunocytochemical	NULL
evidence	NULL
for	NULL
high	NULL
expression	NULL
of	NULL
PML	NULL
proteins	NULL
on	NULL
activated	NULL
macrophages	NULL
,	NULL
endothelial	NULL
cells	NULL
,	NULL
and	NULL
epithelia	NULL
.	NULL

Blood	NULL
85:1871	NULL
,	NULL
1995	NULL
27	NULL
.	NULL

Ponder	NULL
BA	NULL
,	NULL
Wilkinson	NULL
WN	NULL
:	NULL
Inhibition	NULL
of	NULL
endogenous	NULL
tissue	NULL
alkaline	NULL
phosphatase	NULL
with	NULL
the	NULL
use	NULL
of	NULL
alkaline	NULL
phosphatase	NULL
conjugates	NULL
in	NULL
immunohistochemistry	NULL
.	NULL

J	NULL
Histochem	NULL
Cytochem	NULL
29:981	NULL
,	NULL
1981	NULL
28	NULL
.	NULL

Falini	NULL
B	NULL
,	NULL
Abdulaziz	NULL
Z	NULL
,	NULL
Gerdes	NULL
J	NULL
,	NULL
Canino	NULL
S	NULL
,	NULL
Ciani	NULL
C	NULL
,	NULL
Cordell	NULL
JL	NULL
,	NULL
Knight	NULL
PM	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
Grignani	NULL
F	NULL
,	NULL
Martelli	NULL
MF	NULL
,	NULL
Mason	NULL
DY	NULL
:	NULL
Description	NULL
of	NULL
a	NULL
sequential	NULL
staining	NULL
procedure	NULL
for	NULL
double	NULL
immunoenzymatic	NULL
staining	NULL
of	NULL
pairs	NULL
of	NULL
antigens	NULL
using	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

J	NULL
Immunol	NULL
Methods	NULL
93:265	NULL
,	NULL
1986	NULL
29	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Gattei	NULL
V	NULL
,	NULL
Aldinucci	NULL
D	NULL
,	NULL
Degan	NULL
M	NULL
,	NULL
De	NULL
Paoli	NULL
P	NULL
,	NULL
Zagonei	NULL
V	NULL
,	NULL
Pinto	NULL
A	NULL
:	NULL
Expression	NULL
of	NULL
functional	NULL
CD40	NULL
antigen	NULL
on	NULL
Reed-Stemmberg	NULL
cells	NULL
and	NULL
Hodgkin	NULL
's	NULL
disease	NULL
cell	NULL
lines	NULL
.	NULL

Blood	NULL
85:780	NULL
,	NULL
1995	NULL
30	NULL
.	NULL

Lane	NULL
P	NULL
,	NULL
Traunecker	NULL
A	NULL
,	NULL
Hubele	NULL
S	NULL
,	NULL
Inui	NULL
S	NULL
,	NULL
Lanzavecchia	NULL
A	NULL
,	NULL
Gray	NULL
D	NULL
:	NULL
Activated	NULL
human	NULL
T	NULL
cells	NULL
express	NULL
a	NULL
ligand	NULL
for	NULL
the	NULL
human	NULL
B	NULL
471	NULL
cell-associated	NULL
antigen	NULL
CD40	NULL
which	NULL
participates	NULL
in	NULL
T	NULL
cell-dependent	NULL
activation	NULL
of	NULL
B	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
22:2573	NULL
,	NULL
1992	NULL
31	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Gruss	NULL
HJ	NULL
,	NULL
Pinto	NULL
A	NULL
:	NULL
CD40	NULL
ligand	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
T-cell	NULL
lymphomas	NULL
and	NULL
on	NULL
the	NULL
microenvironmental	NULL
reactive	NULL
T-cells	NULL
of	NULL
follicular	NULL
lymphomas	NULL
and	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
147:912	NULL
,	NULL
1995	NULL
32	NULL
.	NULL

Timens	NULL
W	NULL
,	NULL
Visser	NULL
L	NULL
,	NULL
Poppema	NULL
S	NULL
:	NULL
Nodular	NULL
lymphocyte	NULL
predominance	NULL
type	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
is	NULL
a	NULL
germinal	NULL
center	NULL
lymphoma	NULL
.	NULL

Lab	NULL
Invest	NULL
54:457	NULL
,	NULL
1986	NULL
33	NULL
.	NULL

Poppema	NULL
S	NULL
,	NULL
Kaiserling	NULL
E	NULL
,	NULL
Lennert	NULL
K	NULL
:	NULL
Nodular	NULL
paragranuloma	NULL
and	NULL
progressively	NULL
transformed	NULL
germinal	NULL
centers	NULL
:	NULL
Ultrastructural	NULL
and	NULL
immunohistological	NULL
findings	NULL
.	NULL

Virchows	NULL
Arch	NULL
Cell	NULL
Pathol	NULL
31:211	NULL
,	NULL
1979	NULL
34	NULL
.	NULL

Stein	NULL
H	NULL
,	NULL
Hansmann	NULL
M-L	NULL
,	NULL
Lennert	NULL
K	NULL
,	NULL
Brandtzaeg	NULL
P	NULL
,	NULL
Gatter	NULL
KC	NULL
,	NULL
Mason	NULL
DY	NULL
:	NULL
Reed-Sternberg	NULL
and	NULL
Hodgkin	NULL
cells	NULL
in	NULL
lymphocyte	NULL
predominance	NULL
Hodgkin	NULL
's	NULL
disease	NULL
of	NULL
nodular	NULL
subtype	NULL
contain	NULL
J	NULL
chain	NULL
.	NULL

Am	NULL
J	NULL
Clin	NULL
Pathol	NULL
86:292	NULL
,	NULL
1986	NULL
35	NULL
.	NULL

Pinkus	NULL
GS	NULL
,	NULL
Said	NULL
JW	NULL
:	NULL
Hodgkin	NULL
's	NULL
disease	NULL
,	NULL
lymphocyte	NULL
predominance	NULL
type	NULL
,	NULL
nodular	NULL
:	NULL
Further	NULL
evidence	NULL
for	NULL
a	NULL
B	NULL
cell	NULL
derivation	NULL
,	NULL
L	NULL
&	NULL
H	NULL
variants	NULL
of	NULL
Reed-Sternberg	NULL
cells	NULL
express	NULL
L26	NULL
,	NULL
a	NULL
pan	NULL
B	NULL
cell	NULL
marker	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
133:211	NULL
,	NULL
1988	NULL
36	NULL
.	NULL

Korkolopoulou	NULL
P	NULL
,	NULL
Cordell	NULL
J	NULL
,	NULL
Jones	NULL
M	NULL
,	NULL
Kaklamanis	NULL
L	NULL
,	NULL
Tsenga	NULL
A	NULL
,	NULL
Gatter	NULL
KC	NULL
,	NULL
Mason	NULL
DY	NULL
:	NULL
The	NULL
expression	NULL
of	NULL
the	NULL
B-cell	NULL
marker	NULL
mb-1	NULL
(	NULL
CD79	NULL
)	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Histopathology	NULL
24:511	NULL
,	NULL
1994	NULL
37	NULL
.	NULL

Falini	NULL
B	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Pizzolo	NULL
G	NULL
,	NULL
Durkop	NULL
H	NULL
,	NULL
Flenghi	NULL
L	NULL
,	NULL
Stirpe	NULL
F	NULL
,	NULL
Martelli	NULL
MF	NULL
,	NULL
Stein	NULL
H	NULL
:	NULL
CD30	NULL
(	NULL
Ki-1	NULL
)	NULL
molecule	NULL
:	NULL
A	NULL
new	NULL
cytokine	NULL
receptor	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
superfamily	NULL
as	NULL
a	NULL
tool	NULL
for	NULL
diagnosis	NULL
and	NULL
immunotherapy	NULL
.	NULL

Blood	NULL
85:1	NULL
,	NULL
1995	NULL
38	NULL
.	NULL

Poppema	NULL
S	NULL
:	NULL
The	NULL
nature	NULL
of	NULL
the	NULL
lymphocytes	NULL
surrounding	NULL
Reed-Sternberg	NULL
cells	NULL
in	NULL
nodular	NULL
lymphocyte	NULL
predominance	NULL
and	NULL
other	NULL
types	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
135:351	NULL
,	NULL
1989	NULL
39	NULL
.	NULL

Poppema	NULL
S	NULL
,	NULL
Visser	NULL
L	NULL
,	NULL
De	NULL
Leij	NULL
L	NULL
:	NULL
Reactivity	NULL
of	NULL
presumed	NULL
anti-natural	NULL
killer	NULL
cell	NULL
antibody	NULL
Leu	NULL
7	NULL
with	NULL
intrafollicular	NULL
T	NULL
lymphocytes	NULL
.	NULL

Clin	NULL
Exp	NULL
Immunol	NULL
54:834	NULL
,	NULL
1983	NULL
40	NULL
.	NULL

Kuppers	NULL
R	NULL
,	NULL
Rajewsky	NULL
K	NULL
,	NULL
Zhao	NULL
M	NULL
,	NULL
Simons	NULL
G	NULL
,	NULL
Laumann	NULL
R	NULL
,	NULL
Fisher	NULL
R	NULL
,	NULL
Hansmann	NULL
M-L	NULL
:	NULL
Hodgkin	NULL
's	NULL
disease	NULL
:	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
picked	NULL
from	NULL
histological	NULL
sections	NULL
show	NULL
clonal	NULL
immu-noglobulin	NULL
gene	NULL
rearrangements	NULL
and	NULL
appear	NULL
to	NULL
be	NULL
derived	NULL
from	NULL
B	NULL
cells	NULL
at	NULL
various	NULL
stages	NULL
of	NULL
development	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:10962	NULL
,	NULL
1994	NULL
41	NULL
.	NULL

Delabie	NULL
J	NULL
,	NULL
Tierens	NULL
A	NULL
,	NULL
Wu	NULL
G	NULL
,	NULL
Weisenburger	NULL
DD	NULL
,	NULL
Chan	NULL
WC	NULL
:	NULL
Lymphocyte	NULL
predominance	NULL
Hodgkin	NULL
's	NULL
disease	NULL
:	NULL
Lineage	NULL
and	NULL
clon-ality	NULL
determination	NULL
using	NULL
a	NULL
single-cell	NULL
assay	NULL
.	NULL

Blood	NULL
84:3291	NULL
,	NULL
1994	NULL
42	NULL
.	NULL

Migliazza	NULL
A	NULL
,	NULL
Martinotti	NULL
S	NULL
,	NULL
Chen	NULL
W	NULL
,	NULL
Fusco	NULL
C	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Offit	NULL
K	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Frequent	NULL
somatic	NULL
hypermutation	NULL
of	NULL
the	NULL
5	NULL
'	NULL
non-coding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
in	NULL
B-cell	NULL
lymphoma	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
linkage	NULL
to	NULL
immunoglobu-lin	NULL
genes	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
(	NULL
in	NULL
press	NULL
)	NULL
43	NULL
.	NULL

Kamel	NULL
O	NULL
,	NULL
Gelb	NULL
AB	NULL
,	NULL
Shibuya	NULL
RB	NULL
,	NULL
Warnke	NULL
RA	NULL
:	NULL
Leu	NULL
7	NULL
(	NULL
CD57	NULL
)	NULL
reactivity	NULL
distinguishes	NULL
nodular	NULL
lymphocyte	NULL
predominance	NULL
Hodgkin	NULL
's	NULL
disease	NULL
from	NULL
nodular	NULL
sclerosing	NULL
Hodgkin	NULL
's	NULL
disease	NULL
,	NULL
T-cell-rich	NULL
B-cell	NULL
lymphoma	NULL
and	NULL
follicular	NULL
lymphoma	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
142:541	NULL
,	NULL
1993	NULL
44	NULL
.	NULL

Lin	NULL
Y-J	NULL
,	NULL
Johnson	NULL
GD	NULL
,	NULL
Gordon	NULL
J	NULL
,	NULL
MacLennan	NULL
I	NULL
:	NULL
Germinal	NULL
centers	NULL
in	NULL
T-cell-dependent	NULL
antibody	NULL
responses	NULL
.	NULL

Immunol	NULL
Today	NULL
17:17	NULL
,	NULL
1992	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blood	NULL
~	NULL
Distinctive	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
in	NULL
nodular	NULL
lymphocyte	NULL
predominance	NULL
Hodgkin	NULL
's	NULL
disease	NULL
B	NULL
Falini	NULL
,	NULL
B	NULL
Bigerna	NULL
,	NULL
L	NULL
Pasqualucci	NULL
,	NULL
M	NULL
Fizzotti	NULL
,	NULL
MF	NULL
Martelli	NULL
,	NULL
S	NULL
Pileri	NULL
,	NULL
A	NULL
Pinto	NULL
,	NULL
A	NULL
Carbone	NULL
,	NULL
S	NULL
Venturi	NULL
,	NULL
R	NULL
Pacini	NULL
,	NULL
G	NULL
Cattoretti	NULL
,	NULL
E	NULL
Pescarmona	NULL
,	NULL
F	NULL
Lo	NULL
Coco	NULL
,	NULL
PG	NULL
Pelicci	NULL
,	NULL
|	NULL
Anagnastopoulos	NULL
,	NULL
R	NULL
Dalla-Favera	NULL
and	NULL
L	NULL
Flenghi	NULL
4	NULL
QM	NULL
“	NULL
Caw	NULL
,	NULL
.	NULL

,	NULL
'	NULL
\se	NULL
@	NULL
.	NULL

2	NULL
YOtow®	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/87/2/465.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

